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ABSTRACT
Parallel plate flow chambers, simulating in vivo fluid shear stress, provide a real
time insight into the dynamic process of platelet aggregation and investigation of
endothelial cell response to shear stress. This thesis describes the design and validation of
– 1) A simple parallel plate flow chamber to study effects of shear stress on endothelial
cells. This flow chamber is easy to use, inexpensive and fast to manufacture as compared
to the flow devices reported previously. Moreover, it minimizes the number of cells and
solution volumes to be used. It can be used as an effective in vitro system to study the
effects of fluid shear stress on the structure and function of endothelial cells. 2) A four
channel cylindrical flow device, constructed out of polydimethylsiloxane (PDMS) on
microscope coverslips, to study platelet aggregation under in vivo like conditions. The
novel aspect of this flow device is the surface chemistry we have devised for the facile
patterning of immobilized proteins (fibrinogen and collagen) onto polydimethylsiloxane
surfaces. The flow method introduced here was employed to determine the effect of
thymosin β 4, a G-actin sequestering peptide, on the deposition of ADP-activated platelets
onto fibrinogen cross-linked flow chambers. Platelets carry and release large amounts of
thymosin β 4. Yet the role of thymosin β 4 on platelet thrombus formation has not been
fully investigated. We demonstrate that thymosin β 4 has a dual role in platelet
aggregation. Our results show that at low doses thymosin β 4 promotes platelet deposition
and aggregation by yet unknown mechanism. However, platelet adhesion to fibrinogen is
inhibited at high concentrations of thymosin β 4.
Exogenous thymosin β 4 has also been reported to promote wound healing,
inflammation reduction and protection of human cornea epithelial cells against oxidative
damage. Herein, we show that thymosin β 4 can also assuage endoplasmic reticulum
stress in retinal pigment epithelium cells (RPE). Thymosin β 4 pre treatment before
introducing endoplasmic reticulum stress decreases ROS, cholesterol levels and nuclear
translocation of NFκB in RPE.
In conclusion, this body of work demonstrates the utility of flow devices to study
platelet function and effects of shear stress in endothelial cells under in vivo like
conditions. This work also reveals the role of thymosin β 4 in platelet function and
alleviating ER stress in RPE, both of which might of considerable therapeutic relevance.
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CHAPTER – 1

General Introduction

1

1. Platelets
Hemostasis is a co-ordinated event of various cellular and biochemical interactions,
which involves the arrest of bleeding, formation of platelet aggregates and hence wound
healing. Blood platelets play a very important role in every aspect of hemostasis. Platelets
are small (2 to 4 µm in diameter), anuclear and disc-shaped and colourless cellular
structures with a large number of secretory granules. These cells are derived from mature
megakaryocytes via a process called thrombopoiesis. In the circulation of normal human
beings, the number of platelets is in the range of 150,000 to 350,000 per µL. Their
average life span is 6-10 days, after which they are destroyed by phagocytosis in the
spleen.
Platelets have an important role in blood coagulation. Upon vascular injury,
platelets are activated by subendothelial adhesive proteins like collagen and by a wide
variety of soluble agonists including ADP, thrombaxane A2, thrombin and serotonin.
These agonists induce signalling pathways by binding to their respective receptors on
platelets, which leads to various signalling events such as platelet cytoskeletal changes
and granule secretion. Upon activation by the agonists, platelets change their shape and
adhere to newly exposed subendothelial tissues. The contents of the secretory granules (α
granules and dense granules) are released at the site of vascular damage, which play an
important role in haemostasis and thrombus formation (Zucker et al 1985). Platelet shape
change and aggregation are of central importance for the formation of platelet thrombi
and subsequently wound healing. Platelet plug formation at the site of injury occurs in
three stages.
a) Platelet adhesion – Platelets detect vascular damage and adhere to the exposed
subendothelium forming a monolayer of activated platelets.
b) Platelet release reaction – The platelets release active substances that are stored
in their secretory granules. Serotonin, ADP, ATP and calcium are released by
dense granules. Lysosomes release hydrolytic enzymes and α granules release
platelet factor 4 (PF-4), beta thromboglobulin, platelet- derived growth factor
(PDGF), fibrinogen, fibronectin, von Willebrand factor and albumin. The agonists
released by the attached platelets activate and recruit more platelets.
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c) Platelet aggregation – The recruited platelets aggregate with those already bound
and form a platelet plug, which serves as a surface for fibrin deposition. The
platelet plug formed is stabilized, eventually leading to wound healing.

1.1 Platelet receptors and signalling pathways
Platelet adhesion and aggregation on the exposed extracellular matrix (ECM) requires the
coordinated

interaction

of

different

platelet

surface

receptors

with

adhesive

macromolecules. Platelet receptors play a key role in regulating the cascade of events
whereby circulating resting platelets make the rapid transition to an adhered, activated
and aggregated thrombus. The mutation or absence of the receptors or binding proteins
can affect the ability of the platelets to respond to vascular injury.
A wide variety of transmembrane receptors covers the platelet membrane,
including many integrins (αIIbβ3, α2β1), G-protein coupled seven transmembrane receptors
(GPCR) (PAR-1 and PAR-4) thrombin receptors, P2Y1 and P2Y12 receptors and proteins
belonging to the immunoglobulin superfamily (GP VI). Each of these receptors is capable
of binding one or more ligand. Platelet receptors have a prominent role in the hemostatic
function of platelets, allowing specific interactions and functional responses of vascular
adhesive proteins and of soluble platelet agonists. Platelet receptors and their ligands are
listed in Table 1.
TABLE 1 – Platelet membrane receptors and their ligands
Platelet Receptor

Ligands

GP IIb/IIIa, integrin αIIbβ3

Fibrinogen, vWF, Fibronectin

GP Ib-V-IX

vWF

GP Ia/IIa, α2β1

Collagen

Protease activatable receptor (PAR)

Thrombin

α- adrenergic sites

Epinephrine

GP IV, GP VI

Collagen

P2Y1 and P2Y12

ADP

3

Figure 1 – Platelet receptors and ligand interactions (Image taken from Rivera et al
2009).

The platelet membrane receptors bind extracellular factors in response to platelet
activation by different agonists, resulting in platelet adhesion and aggregation. PAR-1 and
PAR-4 in the platelet membrane bind thrombin and mediate adhesion. Collagen can bind
to either GP VI or integrin α2β1. Von Willebrand Factor (vWF), epinephrine and
thromboxane A2 (TxA2) bind to GP Ib/IX/V, α2A and thromboxane receptor (TP)
respectively. The binding of these agonists transmits intracellular signals leading to
elevation of cytosolic Ca2+, cytoskeletal changes, secretion of agonists such as ADP (that
activates G protein-coupled P2Y1 and P2Y12 receptors), and activation of the integrin
αIIbβ3 that binds vWF or fibrinogen and mediates platelet aggregation

4

a) GP VI – It is a 62kDa platelet–specific type 1 transmembrane glycoprotein of the
immunoglobin superfamily. It is an important collagen receptor of high potency in terms
of initiating platelet activation, aggregation and thrombus formation (Nieswandt et al
2003). It is one of the most important members of immunoglobin (Ig) suprefamily on
platelets. It binds ligands including collagen, collagen related peptide (CRP) and the
snake venom protein, convulxin.
Fc receptor gamma (FcRγ) is required for GP VI expression and is associated with
the GP VI via a salt bridge in the transmembrane domains of GP VI (arginine) and FcRγ
(aspartic acid) (Farndale et al 2004). The signalling pathway involves the FcRγ- chain
and the Src kinases (likely Fyn/Lyn), the adapter protein; linker of activated T cells
(LAT), and leads to the activation of phospholipase C gamma 2 (PLCγ2). GP VI initiates
binding to fibrillar collagen under flow conditions, which then activates integrin α2β1
which binds collagen more tightly. GP VI deficiencies cause only a mild bleeding
tendency, probably because integrin α2β1 is able to minimally initiate collagen binding.
b) GP Ib-IX-V – GP Ib-IX-V consists of four transmembrane glycoproteins, which are
all members of the leucine rich protein family (Berndt et al 1995). It is a complex of
glycoproteins constituting GP Ibα and GP Ibβ linked by a disulfide bond, and non
covalently linked to GP IX and GP V. This receptor is constitutively expressed on the
platelet plasma membrane. GPIbα is the major ligand-binding subunit, with a globular Nterminal ligand-binding domain elevated from the cell surface by a sialomucin core
(Andrews et al 2003). It also plays a substantial role in platelet interaction with activated
endothelial cells and with leukocytes, through the binding of P-selectin and Mac-1
(αMβ2), respectively. There are around 25,000 copies of the GP Ib-IX complex per platelet
and there are approximately half as many copies of GP V per platelet, which suggests that
GP V forms a 1:2 complex with GP Ib-IX on the platelet surface (Modderman et al
1992).
Under high shear, GP Ib-IX-V complex interacts with vWF, an extracellular
multimeric adhesive glycoprotein associated with subendothelial matrix, and mediates the
initial adhesion of platelets to the subendothelium. vWF undergoes a conformational
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change when it is bound to matrix or under high shear conditions, which permits its
binding to GP Ib-IX-V complex.

Figure 2 – Platelet signalling through GP VI and GP Ib/IX/V (Image taken from
Rivera et al 2009).
GP VI has a short cytoplasmic tail which binds Fyn and Lyn Src kinases. FcRγ complexes
with GP VI, has an immunoreceptor tyrosine based activation motif (ITAM) which acts
as the signal transducing subunit of the receptor. Collagen binding to the GP VI
phosphorylates ITAM by Src kinases which activate Syk and downstream signalling
pathways. These downstream pathways consist of formation of a signalosome, composed
of various adapter and effector proteins (LAT, SLP-76, Gads), and ultimately activates
PLCγ2. PLC catalyzes the hydrolysis of phosphatidyl inositol 4, 5 bisphosphate (PIP 2),
thus leading to release of inositol 1, 4, 5 triphosphate (IP3) and diacylglycerol (DAG) and
hence integrin activation. The cytoplasmic tail of GP Ibα is associated with filamin and
calmodulin, which links it to the relevant signalling proteins including Src related
tyrosine kinase, focal adhesion kinase (FAK), GTPase activating protein and PI3K. When
vWF binds GP 1b/IX/V, activation signals such as cytoplasmic Ca2+ release, ADP release
and αIIbβ3 activation are elicited. The actual mechanisms as to how these signals are
transmitted are not yet clear.

6

c) Integrins – Integrins are a ubiquitously expressed family of transmembrane receptors
which consist of an α and β subunit. Integrins are present on platelet membrane in a low
affinity state until platelets are activated by agonists. Platelet activation transforms
integrins into a high affinity form and they can bind their ligands. Integrin αIIbβ3 receptor
is a dominant receptor, which is present in large copy numbers (40,000 – 80,000 per
platelet) on the platelet surface. It acts as a principle receptor which mediates platelet
aggregation through binding of plasma fibrinogen (Gruner et al 2003). Its absence or
deficiency causes the most common bleeding disorder Glanzmann thrombasthenia.
The second most important integrin receptor on platelet surface is α2β1. It is the
major collagen adhesion receptor and is present at about 2000 – 4000 copies per platelet.
The α2β1 integrin, commonly referred to as GP Ia/IIa, also plays a role in the adhesion of
platelets to collagen and subsequent optimal activation (Sarratt et al 2005).
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Figure 3 – Integrin activation (Image taken from Nieswandt et al 2009).

Phospholipase C (PLC) is activated after stimulation by the agonists. PLC catalyzes the
hydrolysis of phosphatidyl inositol 4,5 bisphosphate (PIP2) into inositol 1,4,5 triphosphate
(IP3) and diacylglycerol (DAG). IP3 binds and activates IP3 receptors on the endoplasmic
reticulum (ER) membrane resulting in the release of calcium from the ER. Ca2+
concentration inside the cell is further increased by the opening of plasma membrane Ca2+
channel Orail by stromal interaction molecule 1 (STIM1). DAG and Ca2+ activate protein
kinase C (PKC) and diacylglycerol-regulated guanine nucleotide exchange factor I
(CalDAG-GEFI), which further activates and translocates Rap1 to the plasma membrane.
RAP1 effector molecule RIAM interacts with Rap1-GTP and talin-1. This interaction
exposes the integrin binding site of talin-1. The salt bridge between the transmembrane
regions of α and β integrin subunits is disrupted by the binding of talin-1, which results in
a conformational change in the extracellular domains and hence ligand binding. This step
also requires binding of kindlin-3 to the NPXY motif of the integrin β tail.
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d) ADP receptors – ADP plays a central role in regulating platelet function. It induces
platelet aggregation via the activation of 2 major ADP receptors, P2Y1 and P2Y12. ADP
binds the Gq-protein-linked P2Y1 receptor on platelets, which causes a change in cell
shape, mobilization of calcium, and initiation of reversible aggregation. It also binds the
Gi-linked P2Y12 receptor to amplify aggregation via adenylyl-cyclase-mediated cyclic
AMP production (Communi et al 2000). This receptor is also a main target for many antithrombotic drugs. Coactivation of Gq-coupled P2Y1 and Gi-coupled P2Y12 receptors is
essential for ADP-induced platelet aggregation (Jin et al 1998).

9

Figure 4 – ADP receptors and downstream signalling (Image taken from Kim et al
2011).

ADP activates platelets through Gq coupled P2Y1 receptor and Gi-coupled P2Y12 receptor
and causes a number of downstream intracellular signalling events that contribute to
fibrinogen receptor activation and platelet aggregation. G protein gated inwardly
rectifying potassium channels, PI3K, Akt, ERK, Rap 1b and Src family kinases are all
activated through the P2Y12 receptor. Both Rap1b and Akt are signalling mediators that
contribute to platelet aggregation and are activated in a PI3K-dependent manner. RhoA
protein is activated by P2Y1, which causes cytoskeletal and shape changes in activated
platelets. These receptors are also the target of many anti-thrombotic drugs including
clopidogrel, prasugrel and elinogrel. MRS2179 is P2Y1 antagonist.
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1.2 Major proteins involved in thrombosis
Blood coagulation cascade involves numerous different proteins eg fibrinogen, collagen,
tissue factor, factor VII, factor VIII, vWF etc. The properties and functions of 3 major
proteins related to the work in this thesis are described below.
a) Fibrinogen – Fibrinogen is a large (340 kDa), complex glycoprotein which is
primarily synthesized by hepatocytes. It consists of three pairs of polypeptide chains, Aα,
Bβ and γ, linked by 29 disulfide bonds. These polypeptide chains are encoded by different
genes located on chromosome 4. It is normally present in blood plasma at a concentration
of about 2.5g/L with a half life of around 100 h. The primary platelet receptor for
fibrinogen binding is integrin αIIbβ3 (Weisel 2005). Fibrinogen is essential for hemostasis
and plays an important role in wound healing, inflammation and other biological
functions.
Fibrinogen is not only necessary for platelet aggregation, which is an initial step in
hemostasis but also in the formation of insoluble fibrin clots in the final stages of the
blood coagulation cascade. Fibrinogen binds to integrin receptor α IIbβ3 on the activated
platelets and act as a bridge to link platelets causing platelet aggregation and hence
thrombus formation. Human fibrinogen contains three integrin binding sites: two
arginine-glycine-aspartic acid (RGD) sequences within the Aα chain and a non RGD
sequence in the γ chain (Weisel 2005).
Fibrinogen also plays a role during inflammation and immune response and
mediates the adhesion and transendothelial migration of leukocytes. The synthesis of
fibrinogen is increased during inflammation. Two leukocyte integrins, αMβ2
(CD11b/CD18, Mac-1) and αXβ2 (CD11c/CD18) are the main fibrinogen receptors
expressed on neutrophils, monocytes, and macrophages.

Fibrinogen

interacts

with

CD11b/CD18 and intercellular adhesion molecule-1 (ICAM-1) on endothelial cells and
acts as a bridging molecule to enhance leukocyte adhesion to endothelial cells (Languino
et al 1993; Simmons et al 1988).
b) Collagen – Collagen is the most abundant protein in the human body and a major
protein of the extracellular matrix. Collagen plays a major role in the hemostatic cascade.
Platelet adhesion and aggregation on collagen is an integrated process that involves
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various platelet receptors, including GP VI and integrin α2β1. The human genome has
genes for more than 20 forms of collagen. Approximately 9 forms of collagen are
expressed in the vascular wall (Type I, III, IV, V, VI, VIII, XII, XIV), of which types I
and III are the major constituents of the extracellular matrix. Repetitive Gly–X–Y
sequences are the characteristic feature of the primary structure of triple-helical regions of
collagen. Gly– Pro–Hyp (GPO) is the most prevalent sequence, which forms about 10%
of the primary structure of collagen types I and III (Baum et al 1999). For the close
packing of the chains, every third residue must be glycine.
GP Ia/IIa (α2β1) and GPVI are the two major collagen binding receptors present on
platelet membrane. Under normal conditions, collagen is not exposed to flowing blood.
After vascular injury, collagen becomes exposed to the flowing blood; the platelets
adhere to the matrix and form an aggregate. Under high shear rates, platelet adhesion to
collagen requires vWF (Sixma et al 1997).

c) von Willebrand Factor (vWF) – vWF is a multimeric adhesive glycoprotein present
in the plasma, the subendothelial matrix and on the surface of activated endothelial cells.
vWF is stored in storage granules (Weibel-Palade) of endothelial cells and α granules of
platelets and is released upon activation of both types of cells. vWF has binding sites for
platelet GP Iba and GP IIb-IIIa, and for various subendothelial constituents, including
collagen types I, III, and VI. For the initial tethering of flowing platelets at the very high
shear rates found in small arteries and arterioles, the interaction between glycoprotein IbV-IX (GPIb-V-IX) and von vWF immobilized on collagen is very critical (Moroi et al
1999).

1.3 Methods to study platelet function
1. Light transmission aggregometery
Aggregometry has been used as a standard approach to study platelet aggregation in
research. The use of light transmission through platelet suspensions to determine
aggregation was introduced in the early 1960s (Born et al 1962). Shape change and
aggregation can be studied with a platelet aggregometer, which records the transmission
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of light through a stirred platelet suspension. The agonist (ADP, thrombin, collagen) is
added to the platelet suspension and the dynamic measure of platelet aggregation is
recorded over time at 600nm. This platelet aggregation test can be done by using platelet
rich plasma (PRP) maintained at 37o C. When the agonist is added, the platelets aggregate
and absorb less light and so the transmission increases. The change in optical density can
be plotted to view the aggregation curve. Lumiaggregometry is a modification of light
transmission aggregometry which measures platelet secretion along with platelet
aggregation.

2. Cone and plate viscometers
Fluid mechanical forces can exert profound effects on blood cell function. Over the past
years, shear forces generated by blood flow have been recognized to have a significant
impact on platelet adhesion and thrombus formation. Cone and plate viscometers have
been used for the continuous measure of platelet agglutination generated by shear forces
(Fukuyama et al 1989). The role of shear forces in inducing platelet activation has been
measured by subjecting platelets in suspension to a range of shear rates in a viscometer
(Goto et al 1998, 2002; Ikeda et al 1991).
As shown in Fig. 5, the cone is of a very shallow angle and is in bare contact with
the plate. The platelet suspension is placed between the cone and plate and rotation of the
cone at a calculated rate induces shear in the suspension. The rate of shear as well as the
shear patterns can be controlled by the angle of the cone (α), the speed of rotation (ω), the
viscosity of the medium (µ) and the distance between the cone (h(r)) and the plate. The
platelets can be exposed to different range of shear stress and the sample volume required
is around 500µL – 2mL.
A major advantage of a cone and plate viscometer is the constant shear rate
throughout the entire sample. It requires very low volumes of blood/platelet suspensions
and can be used to study both laminar and turbulent flows. It allows measurement of
relatively high shear rates, requires small sample volumes and is easy to clean. The main
disadvantage of the cone and plate viscometer is that it has geometric disparity from the
vessels in the cardiovascular system. Also, it cannot be used to study platelet function in
real time.
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Figure 5 – Cone and plate viscometer.

3. Perfusion chambers
Wall shear has been identified as an important parameter governing the growth of platelet
thrombi. The platelets experience shear stresses in the range of 1 – 60 dyne/cm2 in the
venous and arterial circulation. The perfusion chambers are used to study the influence of
laminar blood flow at various shear rates on thrombus formation.
A perfusion device consists of a perfusion chamber with a glass coverslip, a
pump, vials containing blood/platelet samples and tubing to connect the chamber and the
pump. The matrix proteins (collagen, fibrinogen) are coated on the glass coverslips. The
main advantage of these perfusion chambers is that they allow studies at various
pathophysiological shear rates and also, coating the chamber surfaces with matrix
proteins is a very simple procedure. These perfusion chambers also allow us to study the
dynamics of platelet aggregation in real time. The limitation of these chambers is that
blood flow is pulsatile and blood vessels can dilate, whereas in these flow chambers the
blood flow is constant and walls are rigid.
Parallel plate flow chambers are the most commonly used perfusion chambers to
mimic flow conditions occurring in vivo and study platelet function in vitro. The role of
various platelet membrane receptors, adhesive proteins at the vessel wall, plasma
proteins, thrombin formation and shear rate on platelet adhesion and aggregate formation
can be investigated using these perfusion chambers. Various studies have used these
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parallel plate flow chambers to determine the interaction of platelets with adhesive
surfaces (collagen, fibrinogen, vWF) at various shear rates (Savage et al 1996; Loncar et
al 2006). Tubular flow chambers which retain the cylindrical shape of the vasculature
have been used to study the growth and stability of platelet aggregates and also to study
the flow mechanisms for depositing platelets on various surfaces (Badimon et al 1987).
Flow chambers with built in eccentric cosine shaped stenoses in the blood flow channel
have been used to study the effects of fluid dynamic factors on thrombus formation at
arterial stenotic lesions (Barstad et al 1994). Apart from the conventional flow chambers,
microfluidic devices are also used, which reduce the blood volumes required for platelet
studies (Gutierrez et al 2008).
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Figure 6 – Perfusion Chamber (Image taken from www.dagan.com)
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2. Shear Stress
In normal physiological conditions, various mechanical forces act on blood vessels and
the endothelial cells lining them. Two types of superficial stresses develop at the vessel
walls due to blood flow – circumferential stress due to variation of pulse pressure inside
blood vessels and shear stress due to blood flow. These forces consist of pressure acting
perpendicular to the vessel wall, cyclic strain, and shear stress acting parallel to the wall,
creating a frictional shear force on the surface of the endothelium. Shear stress is
measured in dynes/cm2. For Newtonian fluids flowing upon a planar surface, shear stress
is calculated as
τ=μ

du/dy

where τ is shear stress, μ is kinetic viscosity, u is fluid velocity, y is distance from the
surface and du/dy is the velocity gradient (Shames et al 2003).
The arteries and veins are exposed to different levels of shear stress, which may
produce alterations in the structure, exposure, or clustering of externally oriented
molecules in cell membranes. Normal time-average levels of fluid shear stress in the
venous circulation are approximately 1 – 6 dyne/cm2, and in the arterial circulation
approximately 5 – 60 dyne/cm2. In contrast, higher shear stress values can be observed in
arteries with strong curvatures such as aortic arches, arterioles and vasculature partially
obstructed by atherosclerosis (McDonald et al 1974).

2.1 Role of shear stress in platelet adhesion and aggregation
Shear stress has an important role in maintaining vascular homeostasis. Various studies
have focused on the physiological effects of shear stress. Blood rheology is one of the key
factors regulating the dynamics of thrombus development. The mechanisms of platelet
deposition and thrombus growth are to a large extent determined by the alterations in the
local hemodynamic environment (Mustard et al 1966). In healthy arteries, blood flow is
laminar and platelets are exposed to uniform hemodynamic forces during hemostatic plug
formation. At the site of vascular injury, shear forces generated by the flowing blood play
an important role in platelet adhesion mechanisms. These mechanical forces not only
transport platelets to the vessel wall but also dictate the role of various receptors in
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mediating platelet adhesion. Activation of platelets by pathologically high shear stress can
lead to arterial thrombotic disease.
High fluid shear may trigger platelet aggregation (Kroll et al 1996; Andrews et al
1997). This condition is known as shear induced platelet aggregation (SIPA) and is
known to play an important role in the pathogenesis of various diseases including
atherosclerosis and acute myocardial infarction. Rapid and dramatic changes in blood
flow may activate passing blood platelets. Various studies on effects of shear rates have
shown that increasing shear stress leads to increased deposition of platelets onto
thrombogenic surfaces and increased rates of thrombus growth (Turitto et al 1979; Ikeda
et al 1991; Tsuji et al 1999; Ruggeri et al 2006). A recent study has demonstrated that at
pathological shear rates (> 10,000s-1), large rolling aggregates can develop independently
of integrin αIIbβ3 and platelet activation (Ruggeri et al 2006).
Platelet aggregation is a consequence of the bridging of platelet surface integrin
αIIbβ3, by fibrinogen. Although the receptor complexes in resting or unactivated platelets
do not bind the bridging ligand, high shear forces are thought to induce conformational
changes in the GpIb/IX/V complex or vWF, and consequent platelet aggregation via the
bridging molecule vWF (Ikeda et al 1991; Kroll et al 1996). vWF binding to αIIbβ3is
minimal, but when high shear stresses are applied to platelets, vWF binds to αIIbβ3 as well
as to the GP Ib/IX/V complex, and this binding contributes substantially to direct shearinduced platelet aggregate formation (Goto et al 1995).
In small arteries and arterioles where shear rate is very high, initial platelet
adhesion depends on the binding of GP Ibα to immobilized vWF. This interaction is
crucial for the initial tethering of flowing platelets. This complex continues to recruit
platelets, thereby increasing the shear rate due to growing thrombi, however this binding
is not sufficient to make stable platelet aggregates and the platelets continue to be
translocated in the direction of blood flow. It can keep platelets in contact with the surface
and with each other only for a short time. High shear stress induces binding of platelet
GP-IX-V to plasma von Willebrand factor (vWF) which initiates platelet aggregation
(Savage et al 1998). This molecular mechanism initiates various signalling pathways
which lead to increased intracellular calcium and αIIbβ3 integin receptor activation. This
leads to thrombus formation which can block blood supply to the heart and brain causing
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heart attack and stroke (Kroll et al 1996; Gawaz et al 2004). Activated platelets also
interact with leukocytes circulating in the blood flow and mediate platelet-leukocyteendothelial cell adhesion. In atherothrombosis, platelets promote the interaction of
inflammatory leukocytes with the vessel wall, which initiates formation of atherosclerotic
plaques (Gawaz et al 2004; Massberg et al 2002).

2.2 Endothelial cell responses to shear stress
Endothelial cells constitute the inner lining of blood vessels and constantly experience
fluid shear stress, the tangential component of hemodynamic stresses. When shear stress
is applied on the luminal surface of endothelial cells, the mechanical-chemical signaling
can be transmitted throughout the cell and to cell– extracellular matrix (ECM) adhesions
on the luminal surface of endothelial cells. Endothelial cell surfaces are equipped with
various mechanoreceptors which convert physical stresses into biochemical signals.
Endothelial cells sense shear stress and respond by modifying gene expression,
intracellular signalling, protein expression and other cell functions. Under normal
conditions, the blood flow is unidirectional and laminar, whereas low and disturbed blood
flow promotes development of atherosclerotic plaques (Davies et al 1995).
Numerous studies have been done in vitro and in vivo to demonstrate the effects of
shear stress on the morphology and cellular behaviour of endothelial cells. Sustained
shear stress results in reorientation of the actin cytoskeleton, microtubules, and
intermediate filaments in the direction of flow (Malek et al 1996; Girard et al 1995).
Some of the early responses of endothelial cells to shear stress such as the activation of
Ca2+ and K+ transmembrane channels (Yoshikawa et al 1997) and platelet endothelial cell
adhesion molecule 1 (PECAM-1) phosphorylation (Osawa et al 1997) can be detected
within a few seconds after the onset of flow. Shear stress also leads to the activation and
phosphorylation of various signalling molecules e.g. MAP kinases (Tseng et al 1995),
focal adhesion kinase, jun C terminal kinase (Li et al 1997) and protein kinase C (Traub
et al 1997). Laminar shear stress also enhances endothelial cell migration in wound
healing (Li et al 2002; Hsu et al 2001; Albuquerque et al 2000). Physiological shear
stress decreases the rate of apoptosis from growth factor depletion, tumor necrosis factor
α or hydrogen peroxide exposure (Levesque et al 1990; Chiu et al 1998) via activation of
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Akt and attenuated caspase mediated killing (Dimmeler et al 1996).
Prolonged shear stress causes distinct structural and morphological changes in
endothelial cells and also affects the overall vascular tone through the regulation of
various vasoconstrictors and vasodilators. Shear stress is essential to maintain endothelial
integrity and cardiovascular health. It has been shown that fluid shear stress plays an
important role in blood vessel formation and maintenance although the mechanisms are
not fully understood yet.
2.3 Shear stress sensors
The ability of endothelial cells to respond to shear stress indicates that they can sense
shear stress as a signal. Various studies have been done to understand the mechanisms of
signal mechanotransduction in shear stress. Shear stress is detected by various receptors,
tranducers and sensor proteins on the cell surface and multiple pathways are involved in
the shear stress signal transduction including G proteins, tyrosine kinase receptors,
caveolae and ion channels.
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Figure 7 – Mechanotransduction of endothelial shear stress (Image taken from
Chatzizisis et al 2007).

Shear stress is sensed by various mechanoreceptors including integrins, caveolae, ion
channels, G coupled proteins, tyrosine kinase receptors and proteoglycans. Integrins are
activated when shear stress signals are transmitted through the cytoskeleton to the basal
endothelial surface. Various other proteins and protein complexes including adaptor
proteins (Grb2, Crk), non receptor tyrosine kinases (FAK, c-Src, Shc, paxillin, p 130CAS)
and guanine nucleotide exchange factors (Sos and C3G), are phosphorylated and
activated by the integrins. This activates the Ras family GTPase, which triggers
downstream cascades of serine kinases, ultimately activating mitogen activated protein
kinases (MAPKs). Shear stress signals transmitted through the cytoskeleton to the
junctional or luminal endothelial surface activates protein kinase C (PKC), Rho family
small GTPases which mediate cytoskeletal remodelling and phosphoinositide 3 kinase
(PI3K) - Akt cascade. All of these signalling pathways lead to phosphorylation of various
transcription factors, which bind to shear stress responsive elements (SSPE) at promoters
of mechanosensitive genes, thereby inducing or suppressing their expression
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2.4 Shear stress, endothelial dysfunction and atherosclerosis
Atherosclerosis is a chronic and inflammatory disease of conduit arteries and is the
leading cause of death in developed countries. It is associated with several other well
defined risk factors including hypertension, hyperlipidemia and diabetes mellitus. The
atherosclerotic lesions form at specific regions of the arterial tree, such as in the vicinity
of branch points, the outer wall of bifurcations, and the inner wall of curvatures, where
disturbed flow occurs. It has been widely shown that atherosclerosis preferentially
develops in vascular regions with low shear (Malek et al 1999; Nerem et al 1993). On the
other hand, the vessel regions which are exposed to laminar, steady and high shear flow
remains disease free.
Sterol regulatory element binding proteins (SREBPs) are also activated by low
shear stress. These endoplasmic reticulum-bound transcription factors upregulate the
expression of genes encoding the LDL receptor, cholesterol synthase, and fatty acid
synthase (Liu et al 2002). SREBPs also increase the permeability of the endothelial
surface to LDL (Traub et al 1998) and production of reactive oxygen species (ROS). The
circulatory inflammatory cells (monocytes, T lymphocytes and mast cells) are recruited
into the tunica intima, the innermost layer of the arteries, to scavenge oxidized LDL.
NFκB is activated which upregulates genes encoding vascular cell adhesion molecule-1
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant
protein (MCP)-1; and pro-inflammatory cytokines, such as tumor necrosis factor α (TNF
α) and interleukin (IL)-1. These adhesion molecules mediate rolling and adhesion of
leukocytes on endothelial cells. MCP-1 promotes recruitment of leukocytes into the
intima. After leukocyte infiltration into endothelial cells, they differentiate into
macrophages, which sustain inflammation and hence promote atherosclerosis.
Shear stress is also associated with endothelial proliferation. Endothelial cell
proliferation increases by 18 times within 48 hours of shear stress reduction (Mondy et al
1997). Decrease in shear stress also causes vascular smooth muscle cell proliferation,
differentiation and migration into the intima, endothelial cell loss and decrease in actin
stress fibres (Walpola et al 1993, 1995).
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Figure 8 – Effects of disturbed shear rates on endothelial cell function (Image taken
from Malek et al 1999).
Hemodynamic shear stress is very important for maintaining endothelial integrity and
function. Arterial-level shear stress (>15 dyne/cm2) induces endothelial quiescence by
decreasing proliferation and apoptosis. It also upregulates the expression of
atheroprotective genes including eNOS. However, low shear stress (<4 dyne/cm2), which
is prevalent at atherosclerosis-prone sites, stimulates an atherogenic phenotype by
decreasing antioxidants production and atheroprotective genes. Increased expression of
VCAM and MCP-1 activates the monocytes, enhancing the progression of atherogenesis.
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2.5 Parallel plate flow chambers
To study the dynamic response of vascular endothelial cells to controlled levels of fluid
shear stress, various types of in vitro systems that allow cultured endothelial cells to be
exposed to well-defined flow conditions have been developed. These systems include a
cone-plate apparatus (Dewey et al 1981), orbital shakers (Dardik et al 2005), capillary
flow tubes (Olesen et al 1988; Jacobs et al 1995), and parallel-plate flow chambers
(PPFC) (Ruel et al 1995; Chiu et al 1998).
Among in vitro systems employed to study the effects of flow conditions on
endothelial cells, PPFC have been the most commonly used for flow stimulation of
endothelial cells (Brown et al 2000). PPFC are generally used to mimic shear flow on
cultured endothelial cells. A typical PPFC consists of a silicon gasket, a polycarbonate
distributor, which has inlet and outlet ports, and a glass coverslip on which endothelial
cells are grown. The endothelial monolayer is subjected to fluid flow by creating a
pressure gradient along the chamber. The design of PPFCs is very simple and they are
very easy to operate. The main advantage of PPFC is that it can be used to produce shear
rates ranging from 0.01 – 60 dyne/cm2 and studies can be visualized in real time.
Studies using the PPFC have provided insight into the effects of shear on
endothelial cell alignment and elongation, aided investigators in fine tuning the
application and adjustment of shear and helped lay the groundwork for future devices.
For example, endothelial cells have been subjected to steady and pulsatile shear stress to
measure and correlate their production of prostacyclin (Hanada et al 2000; Grabowski et
al 1985), determine their orientation with respect to flow direction and reveal that higher
shear stress results in a higher degree of cell elongation (Levesque et al 1985).
Mechanotransduction in endothelial cells has been studied using many in vitro and in vivo
approaches.
PPFCs have been used to study the effects of shear stress on the apoptosis of
HUVECs induced by lipopolysaccharide (LPS) (Zeng et al 2005) and expression of
proto-oncogenes, c-fos and c-myc in HUVECs (Li et al 2002). The effects of fluid shear
stress on MCP-1 induction in endothelial cells have also been investigated using PPFCs
(Yu et al 2002). PPFCs have also been used to study the mechanisms underlying
proliferation, adhesion and metastasis of cancer cells (Zhang et al 2003).
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3. Thymosin β 4
Thymosins are a group of peptides which were first isolated from calf thymus. These are
divided into 3 different groups based on their isoelectric point: α thymosin (pI < 5), β
thymosin (5 < pI < 7) and γ thymosin (pI > 7). β thymosins are a family of structurally
related proteins, which have highly conserved amino acid sequences among different
species. Thymosin β 10 and thymosin β 15 are expressed in breast, thyroid and prostate
metastatic tumors and are thought to be the prognostic markers of these cancers (Bao et al
1996; Santelli et al 1999). There are 16 members of the β thymosin family and thymosin
β 4 (Tβ4) is the most studied of all the members of the family.
Tβ4 is a highly conserved peptide, which was first isolated from thymus tissue in
1981 (Low et al 1981; Yu et al 1994). It has 43 amino acids with a molecular weight of
4.9 kDa. It is found in concentrations of 10 nM – 600 M in different tissues and cell
types (Hannappel et al 1985, 1987). The concentration of free Tβ4 in blood is about 10–
200 nM (plasma and serum). It is regarded as a major intracellular G actin sequestering
peptide in mammalian cells. It forms a 1:1 complex with G actin and inhibits its salt
induced polymerization to F actin (Hannappel et al 1993; Huff et al 2001). Tβ4 is also
present inside the cell and extracellular fluid.

3.1 Structure and properties
Tβ4 has a dynamic and flexible conformation. Three dimensional structure
determinations by NMR-techniques have demonstrated that Tβ4 is unstructured in
aqueous solutions. However, when fluorinated alcohols are added to the aqueous solution
a defined 3D-structure can be obtained (Zarbock et al 1990). The data obtained under
these conditions indicated that Tβ4 is a rather extended molecule of almost 5 nm in
length. Both the N- and C-terminal conserved sequence stretches ranging from residues 5
to 15 and 30 to 40, respectively, form short α-helices linked by a flexible loop.
Proteins which lack a definite secondary structure in aqueous solutions attain a
defined tertiary structure on binding their target proteins and undergo a number of
structural intermediate states after forming the initial collision complex (Sugase et al
2007). Due to their ability to attain different conformations, such proteins can also
interact with a number of different proteins. β thymosins might also behave in a similar
25

way. In other words, their binding to actin may induce a stable three-dimensional
structure with defined secondary structural elements. The ability to adopt different
conformations might explain the promiscuous protein interactions and multiple
extracellular functions of β thymosins.

3.2 Biological functions
Various studies have shown diverse biological roles of Tβ4. It promotes wound repair,
angiogenesis, cell migration, tissue protection, regeneration in the skin, eyes and heart,
and prevents apoptosis and inflammation.
3.2.1 Tβ4 promotes cell migration and adhesion
The regulation of polymerization and depolymerization of actin subunits is a key
mechanism by which Tβ4 enables cells to migrate (Malinda et al 1997; Grant et al 1995).
It also upregulates the gene expression of laminin -5, a subepithelial basement membrane
protein believed to be one of the best ligands for keratinocyte adhesion and migration,
and influences cell migration (Sosne et al 2004). Tβ4 also activates Akt, which plays a
very potent role in cell growth, survival and motility (Bock-Marquette et al 2004). During
the morphological differentiation of endothelial cells into capillary-like tubes, there is a
five fold increase in Tβ4 mRNA level. When the endothelial cells are transfected with
Tβ4, there is an increased rate of attachment and spreading on matrix components and an
accelerated rate of tube formation on Matrigel (Grant et al 1995). Tβ4 also stimulates the
migration of HUVECs (Malinda et al 1997) and induces matrix metalloproteinase 2 in
vitro and in vivo (Malinda et al 1999). Another study indicated that local production of
Tβ4 is increased during muscle injury and it promotes myoblast migration, hence
facilitating skeletal muscle regeneration (Tokura et al 2011).
3.2.2 Tβ4 prevents apoptosis and promotes cell survival, angiogenesis and cell
differentiation
Tβ4 has been shown to reduce apoptosis and promote induction of anti apoptotic genes. A
previous study on the pro-apoptotic effects of ethanol on corneal epithelial cells has
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shown that Tβ4 decreases cytochrome c release from the mitochondria and caspase
activation. It also increases the expression of anti-apoptotic protein, bcl-2 (Sosne et al
2004). In cardiomyocytes, it activates the phosphoinositide/Akt cell survival signalling
pathway and inhibits endothelial apoptosis (Hinkel et al 2008).
Tβ4 is known to be an important angiogenic molecule that promotes angiogenesis
by differentiation and directional migration of endothelial cells (Malinda et al 1997;
Grant et al 1999). It promotes coronary vessel development and collateral growth during
embryonic development and also stimulates epicardial vascular progenitors which can
later differentiate into endothelial and smooth muscle cells (Smart et al 2007). Tβ4 has
been shown to induce dermal repair and hair growth by promoting stem cell migration
and differentiation into keratinocytes and hair follicles (Philip et al 2004).
3.2.3 Role of Tβ4 in thrombosis
The concentration of Tβ4 is very high in white blood cells and in plasma is very low,
however during blood clotting, Tβ4 concentration in the serum increases substantially. In
1987, it was shown that Tβ4 is present in human blood platelets in very high
concentrations (Hannappel et al 1987). In resting platelets, the Tβ4 concentration is ~
560µM, of which ~ 280µM is in complex with G actin and ~280µM is free (Nachmias et
al 1993).
During blood coagulation or ADP induced aggregation of platelets Tβ4 is
liberated from platelets and partially cross-linked to fibrin by a transglutaminase, factor
XIIIa (Huff et al 2002). Tβ4 crosslinking to the fibrin occurs in a time and Ca2+
dependent manner. Factor XIIIa incorporates Tβ4 preferentially into the fibrin αCdomains, a domain often used to attach biologically active peptides to fibrin
(Makogonenko et al 2004). The covalent cross-linking of Tβ4 to the fibrin clot might
represent a mechanism to guarantee a high local concentration of the peptide at the site of
injury probably supporting subsequent wound healing.

This could be a potential

molecular mechanism to bring Tβ4 near the site of vascular injury and leads to clotting
and wound repair by Tβ4.
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Figure 9 – Tβ4 and blood coagulation (Image taken from Huff et al 2002).
When the platelets are stimulated with ADP, various cytoskeletal changes take place. The
platelets change shape and there is secretion of ADP, Factor V, Tβ4, serotonin,
thromboxane A2 and growth factors. The platelets aggregate and form a platelet plug,
which must be stabilized by a fibrin clot to ensure wound closure. The fibrin monomers
attach to the platelet plug and are further cross linked by factor XIII to form an insoluble
clot. Tβ4 released from the platelets is also fixed to the fibrin clot by factor XIII
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3.2.4 Role of Tβ4 in inflammation and corneal wound healing and repair
Previous studies have shown that Tβ4 decreases inflammation and promotes corneal
wound healing. It decreases matrix metalloproteinases and proinflammatory cytokines
and chemokines. In mouse models, topical application of Tβ4 after alkali injury
downregulates the expression of the potent chemoattractants, macrophage inflamatory
protein 2 (MIP 2) and keratinocyte chemoattractant (KC) in the cornea (Sosne et al 2002).
It also accelerates epithelial cell migration and re-epithelialization after alkaline and
alcohol injuries and scrape wounding in a dose-dependent manner in rat corneal wound
models (Sosne et al 2002, 2005). Tβ4 has been shown to protect corneal endothelial cells
from apoptosis and oxidative stress induced by low dose ultraviolet B (UVB) exposure
(Ho et al 2010). It protects human corneal epithelial cells against Fas ligand (Fas-L) and
H2O2 induced damage. Internalization of Tβ4 is critical for its cytoprotective effect (Ho et
al 2007).
Tβ4 is hypothesized to be an anti-inflammatory agent. It interferes with the NFκB
signalling pathway, which is activated by the potent pro-inflammatory cytokine TNFα.
Tβ4 pre treatment reduces nuclear NFκB protein levels, NFκB activity, and p65 subunit
phosphorylation, and nuclear translocation in corneal epithelial cells stimulated with TNF
α (Sosne et al 2007). No receptors have been identified for Tβ4 thus far. Future
investigation of putative Tβ4 receptors would provide critical information for
understanding how extracellular Tβ4 exerts its biological activities in cells.

29

4. Retinal Pigment Epithelium
Retinal pigment epithelium (RPE) is a monolayer of pigmented cuboidal cells present
between the retinal photoreceptors and choriocapillaris. It is separated from the
choriocapillaris, which supplies blood flow to the RPE, and the outer one-third of the
retina (including the photoreceptors), by Bruch’s membrane. The human RPE
incorporates approximately 3.5 million epithelial cells arranged in a regular hexagonal
pattern. RPE are bound together by junctional complexes with prominent tight junctions.
These junctions divide the cells in an apical half that faces the retina and a basal half that
faces the choroid (Hudspeth et al 1973). The only anatomical contact between the
photoreceptors and RPE is the interphotoreceptor matrix. Under pathological conditions
such as retinal detachment, fluid accumulates in the subretinal space and photoreceptors
are separated from the RPE. This causes a loss of photoreceptor function.
The embryonic development and differentiation of RPE and photoreceptors is
interrelated. Both photoreceptors and choriocapillaries depend on the RPE for their
survival. RPE is crucial for the development of the retina. It secrets various growth
factors required for photoreceptor differentiation and survival. It has been shown in an
animal model of retinal dystrophy, that RPE secretes basic fibroblast growth factor
(bFGF), which promotes the survival of photoreceptors (Faktorovich et al 1990).
Neuronal retina and photoreceptors are affected the most by RPE loss.
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Figure 10 – Retinal pigment epithelium. (Image taken from www.dev.ellex.com)

4.1 RPE Functions
RPE is involved in a variety of functions which includes phagocytosis of shed outer
segments, transport of vitamin A to the photoreceptors and maintenance of normal
physiology of the choriocapillaries (Bok et al 1993). RPE transports electrolytes and
water from the subretinal space to the choroid, also transports glucose and other nutrients
from the blood to the photoreceptors.
a) Light absorption – RPE increases optical quality by helping in absorption of the
scattered light. RPE pigmentation is very critical to maintain visual function. It contains a
complex composition of various pigments (melanin, lipofuscin) which absorb different
wavelengths of light. Melanin is the main pigment of RPE present within cytoplasmic
granules called melanosomes. It absorbs stray light and minimizes light scattering within
the eye. The retina has a direct and frequent exposure to light which causes the photo31

oxidation of lipids, which can be extremely toxic to retinal cells (Girotti et al 2004). The
retina also generates large amounts of reactive oxygen species (ROS) due to its high
oxygen consumption. RPE counterbalances the high oxidative stress present in the retinal
cells by maintaining large amounts of enzymes like superoxide dismutase (SOD) and
catalase (Frank et al 1999; Tate et al 1995) and non enzymatic antioxidants like
ascorbate, lutein and zeaxanthin (Newsome et al 1994; Beatty et al 2000), which act as a
defence system against the oxidative stress.
b) Transport nutrients and ions – RPE transports nutrients like glucose, retinol and
fatty acids from blood to the photoreceptors. It has large numbers of glucose transporters
GLUT 1 and GLUT 3 in its apical and basolateral membranes (Ban et al 2000). With the
help of these glucose transporters, RPE transfers glucose from the blood to the
photoreceptors. GLUT1 induces glucose transport in response to mitogens and hence
adapts glucose transport according to the metabolic needs of the retina. During the visual
cycle, the bulk of retinal is exchanged between RPE and the photoreceptors. The RPE
takes all-trans retinol from the photoreceptors, oxidizes and isomerizes it to 11-cis retinal
and redelivers it to the photoreceptors (Baehr et al 2003). Docosahexaenoic acid (DHA)
is an essential omega 3 fatty acid which is required as a structural element of
photoreceptor and neuron membranes, however, DHA cannot be synthesized by the
neural tissues and is hence transported by RPE from blood to the photoreceptors
(Anderson et al 1992).
Due to the high metabolic turnover in the photoreceptors, a large amount of water
is produced in the retina. Also, there is movement of water from the vitreous body to the
retina due to intraocular pressure (Marmor et al 1990; Hamann et al 2002). Hence, there
is a constant need for removal of water from the retina. RPE transports water and ions
from the subretinal space to the blood (Hughes et al 1998). It also eliminates metabolic
end products of the photoreceptors. Photorecpetor outer segments produce lactic acid and
its subretinal concentration is estimated to be around 19 mM (Adler et al 1992; Hsu et al
1994). RPE removes lactic acid from the subretinal space through lactate-H+
cotransporter MCT1 (Lin et al 1994; Philip et al 1998) and Na+ dependent transporter for
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organic acids (Kenyon et al 1994). The Na+-K+-ATPase, which is located in the apical
membrane, provides the energy for transepithelial transport (Marmorstein et al 2001).
c) Phagocytosis – When the photoreceptors are exposed to high intensities of light, there
is an increase in concentration of light induced toxic substances like photo oxidative
radicals and photo damaged proteins and lipids, in the photoreceptors (Beatty et al 2000).
To maintain the excitability of the photoreceptors, the photoreceptor outer segments
undergo a constant renewal process (Young et al 1969; Nguyen-Legros et al 2000). The
highest concentration of these toxic substances is present in the tips of the photoreceptor
outer segments. Hence, these tips are shed from the photoreceptors and new tips are
formed from the base of outer segments, at the cilium. The shedding of tips and the
formation of new tips is very well coordinated, so that the length of photoreceptor outer
segments is maintained. The shed tips are phagocytosed and digested by RPE. Retinal and
docosahexaenoic acid are transported back to the photoreceptors to rebuild the outer
segments (Bok et al 1993; Bibb et al 1974).
d) Secretion – RPE secretes a large number of growth factors which are essential for the
maintenance of the structural integrity of the retina. It secretes fibroblast growth factors
(FGF-1, FGF-2 and FGF-5), insulin like growth factor-1 (IGF-1), VEGF, pigment
epithelium derived factor (PEDF), platelet derived growth factor (PDGF) and lens
epithelium derived growth factor (LEDGF).
Although VEGF is secreted in very low quantities by RPE, it plays an important
role in maintaining intact endothelium of the choriocapillaries (Adamis et al 1993; Burns
et al 1992). A neuroprotective factor PEDF secreted by RPE protects neurons against
glutamate and hypoxia induced apoptosis (Cao et al 2001). It stabilizes the endothelium
of choriocapillaries (King et al 2000) and plays an important role in the embryonic
development of the eye (Behling et al 2002).

Another peptide secreted by RPE is

somatostatin, which plays an important role in retinal homeostasis. Somatostatin acts as a
neuromodulator through different pathways including intracellular calcium signalling
(Johnson et al 2001) and glutamate release from the photoreceptors (Akopian et al 2000).
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e) Retinoid cycle – One of the most important functions of RPE is its role in the visual or
retinoid cycle, which involves repeated movement of retinoid and its derivatives between
photoreceptors and RPE (Bok et al 1993). The light is absorbed by rhodopsin, which is
composed of the G-coupled receptor protein opsin and chromophore 11-cis –retinal. After
light absorption, 11-cis-retinal is converted into all-trans retinal. The photoreceptors lack
cis-trans isomerase function for retinal and are unable to regenerate 11-cis-retinal from
all-trans-retinal. The main purpose of the visual cycle is to regenerate 11-cis retinal,
which acts as a chromophore for the visual pigments of outer segments of photoreceptors.
All-trans-retinal is reduced to all-trans-retinol and is transported to RPE. The
isomerisation is the first step in phototransduction and takes place in RPE. In RPE, retinol
is oxidized and reisomerized to 11-cis-retinal by the enzyme retinal pigment epitheliumspecific proten (RPE65) and is delivered back to the photoreceptors (Hargrave et al 2001;
Pang et al 2006; Bernstein et al 1987). Interphotoreceptor retinoid binding protein (IRBP)
mediates the transport of retinoids between RPE and photoreceptors. IRBP is a large
glycoprotein present in the RPE endosomes and interphotoreceptor matrix (IPM)
(Cunningham et al 2003; Wu et al 2007; Gonzalez-Fernandez et al 2008). IRBP
solubilises retinal and retinol and mediates the direction of transport of these compounds
(Okajima et al 1989; Pepperberg et al 1991).

4.2 RPE ageing and diseases
A variety of structural and biochemical changes occur in RPE with increasing age. There
is increase in atrophy, hyperpigmentation and loss in cell shape. With advancing age,
there is also a decrease in the concentration of RPE cells in the posterior pole. The
melanin content of RPE also decreases with age (Salvi et al 2006). Senescent RPE
accumulate metabolic debris from remnants of incomplete degradation of phagocytized
rod and cone membranes (Ciulla et al 2001). Ingestion of outer segments of
photoreceptors puts a heavy phagocytic burden on RPE, which results in the
accumulation of lipofuscin between RPE and Bruch’s membrane. Lipofuscin is an
undegradable byproduct of outer segment photoreceptor metabolism which increases in
RPE over time. The accumulation of lipofuscin is involved in the pathogenesis of various
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retinal diseases like age related macular degeneration (AMD) and is one of the major
characteristic features of ageing in RPE. Lipofuscin is continuously exposed to light and
high oxygen tension, which leads to production of reactive oxygen species (ROS) and
causes oxidative damage to mitochondria and mitochondrial DNA. The production of
antioxidants, which RPE produces to counteract oxidative stress, also decreases with age
(Liang et al 2003). Mitochondrial damage affects the cellular and physiological
functioning of RPE. This leads to decrease in energy production and subsequently signals
apoptosis eventually decreasing the number of RPE (Zarbin et al 2004).
Under normal conditions, RPE secretes various growth factors which can protect
photoreceptors from damage. There is constant balance between angiogenic and antiangiogenic growth factors within the eye. Imbalance between the secretion of these
growth factors leads to choroidal neovascularisation (Bhutto et al 2006). PEDF and
VEGF are two growth factors secreted by RPE, which cross regulate each other. VEGF
gene expression increases angiogenesis whereas PEDF acts as an antagonist and inhibits
angiogenesis (Tsai et al 2006; Dawson et al 1999). To regulate angiogenesis in the retina,
balance between these two growth factors is very essential (Tong et al 2006). Previous
studies have shown that VEGF is upregulated in RPE and choroid complex in patients
suffering from AMD (Tsai et al 2006). Decreased PEDF levels in the vitreous samples of
AMD patients have also been reported (Holekamp et al 2002).

4.2.1 Age related macular degeneration (AMD) – AMD is the major cause of blindness
in elderly people. The atrophic or dry form of AMD is caused by progressive degradation
of RPE and the photoreceptors. In AMD, vision loss occurs as a result of photoreceptor
damage in the central retina; however the initial pathogenesis involves RPE degeneration
(Zarbin et al 1998). Since RPE is involved in the metabolic and nutritional aspects of the
photoreceptors, RPE dysfunction can cause secondary degeneration of the photoreceptors.
Age-related processes that occur in the retinal pigment epithelium-Bruch’s membranechoriocapillaris complex can precede the development of AMD (Liang et al 2003). AMD
is associated with an accumulation of lipofuscin, a pigment formed in tissues with high
levels of oxidative stress. Early AMD is characterized by thickening and loss of normal
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architecture within Bruch’s membrane, lipofuscin accumulation in the RPE, and drusen
formation beneath the RPE in Bruch’s membrane. The primary clinical characteristic of
late stage dry AMD is the appearance of RPE atrophy. It is characterized by roughly oval
areas of hypopigmentation and is usually the consequence of RPE cell loss. Loss of RPE
cells which provide nutrition to the photoreceptors leads to the gradual degeneration of
nearby photoreceptors, resulting in a progressive visual impairment.
4.2.2 Retinitis pigmentosa – Retinitis pigmentosa is an inherited form of retinal which is
characterized by pigment deposits in the retina. It involves degeneration of photoreceptors
rods and cones and deposits in the retinal pigment epithelium. The accumulation of
metabolic waste products lead to lipofuscin formation which affects the function of the
RPE. The inability of RPE to phagocytose photoreceptor outer segments causes an
autosomal recessive form of retinitis pigmentosa (Edwards et al 1977; Wang et al 2001).
4.2.3 Diabetic retinopathy – Diabetic retinopathy (DR) is one of the leading causes of
blindness in developed countries. DR is characterized by decreased levels of glutathione,
SOD and ascorbic acid (Madsen-Bouterse et al 2008; Silva et al 2009; Minamizono et al
2006). A recent study has shown that there is a decrease in IRBP production in early
diabetic retinopathy (Garcia-Ram´ırez et al 2009). IRBP is required for retinoid transport
between RPE and photoreceptors and is critical for the visual cycle.
Increased production of VEGF, an angiogenic factor, plays an important role in
the pathogenesis of DR. There is a decreased expression of the anti-angiogenic factor,
PEDF, by elevated glucose concentration in cultured human RPE cells (Yao et al 2003).
New therapeutic approaches for DR which involve blocking VEGF and stimulating PEDF
have been proposed. The development of DR is also favoured by the decreased
expression of somatostatin (Carrasco et al 2007). Somatostatin plays an important role in
preventing neovascularisation and fluid accumulation within the retina. These functions
are greatly impaired due to downregulation of somatostatin expression, thus leading to
development of DR (Hern´andez et al 2005; Sim et al 2007).
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CHAPTER 2

Development of flow device to study effects of shear stress on
endothelial cells and its applications
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Introduction
Endothelial cells are exposed to various mechanical stimuli such as shear stress,
hydrostatic pressure and cyclic stretch due to vessel deformation. These stimuli alter
endothelial cell morphology, initiate cytoskeletal changes and activate various signalling
pathways. The nature and magnitude of these hemodynamic forces has an important role
in maintaining vascular homeostasis.
Laminar shear stress is one of the most potent endothelial stimulators, which is
very critical for normal vascular functioning. It plays an important role against
inflammatory activation and apoptosis (Tricot et al 2010; Chien et al 2008). Disturbed
shear stress has been implicated in the pathogenesis of various diseases including
atherosclerosis and cardiovascular diseases (Traub et al 1998).
In the past few years, physiological and pathological shear stress has been studied
extensively to understand the development and progression of vascular diseases. To
understand the effects of these hemodynamic forces in vitro, engineered devices are
required that can maintain the endothelial cells in a controlled in vivo like environment.
The fluid flow must be predictable in these devices so that shear stress over endothelial
cells can be properly controlled.
Many in vitro flow systems have been developed to study endothelial cells under
shear stress. These flow devices require a large population of endothelial cells which
needs more chemicals and reagents. Recently, many studies have reported the
development of microfluidic flow chambers. Some of these designs have multiple
microchannels to study different cell types and shear rates at the same time (Young et al
2007). A major drawback of such flow devices is cross contamination between different
channels. Some of these flow devices and microfluidic devices have been custom
laboratory prototypes, while others are commercially available.
In the present study, we describe the construction and testing of a simple and
robust parallel plate flow chamber. The aim of this study was to develop an in vitro model
using a parallel-plate flow chamber to simulate in vivo fluid shear stresses on endothelial
cells exposed to dynamic fluid flow in their physiological environment. A computational
fluid dynamics (CFD) template was developed for simulation and prediction of flow
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induced shear rates on the endothelium, while an in vitro model was used to investigate
the subsequent cellular biological responses.
The flow chamber was validated by determining changes in the production of
nitric oxide and caveolin-1 expression in bovine endothelial cells exposed to shear stress.
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Experimental Methods
Cell culture
Bovine aortic endothelial cells (BAECs) were purchased from Coriell Institute for
Medical Research. The cells were cultured in DMEM F-12 media containing 10% fetal
calf serum (FCS, Gibco) and penicillin-streptomycin, at 37°C in a humidified atmosphere
of 95% air and 5% CO2.

Parallel plate flow chamber configuration
The flow apparatus used in this study is a parallel plate flow chamber with a closed loop
system (Figure 1).

CFD simulation and viscosity measurement
In order to use the velocity gradient templates as shear stress templates, the viscosity of
the media at 37ºC was required. A viscometer (Canon Instruments, Model 2085, PA,
USA) and viscosity bath, set to 37ºC, were used. The media was injected into the
viscometer and allowed to reach equilibrium conditions before being suctioned to the top
of the viscometer and then released while the time it takes the fluid to flow through a
defined section was measured. Using equipment specific correlations, the viscosity was
calculated based on the time taken to pass through a defined section. This process was
repeated five times and an average viscosity was calculated and used in the shear stress
calculations. The specific gravity of the media was determined by using a calibrated
hydrometer. The average viscosity was 0.753 cP (0.00753 Pa∙s).

Calculation of shear stress
Shear stress was calculated according to the following formula:

 

dy
dz

Where μ is the viscosity of the media and dy/dz is the velocity gradient of the flow. From
the templates generated in FLUENT the values of the velocity gradients at various
regions on the plate are known. Since the viscosity of the media has been measured, the
shear stress can be directly calculated and an average shear stress for each region on the
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template can be defined. The shear stress values used in our investigations ranged from
0.05 to 1.47 Pa, which is within the physiological range for aortas (~0.002 Pa) and veins
(~0.01 Pa).

Shear stress studies
Bovine endothelial cells were grown on coverslips in 35mm cell culture plates. The cells
were exposed to shear stress using a peristaltic pump (Reglo Digital MS 4/6, model ISM
833, Ismatec). PTFE tubing (Scientific Products & Equipment, Canada) was used to link
the pump and the flow chamber. Shear stress experiments were performed for 16 hours in
complete media in 5% CO2 incubator at 37°C.

Measurement of NO production
To determine changes in NO production, endothelial cell monolayers were incubated with
cell culture medium containing 5 M 4,5-diaminofluorescein diacetate (DAF-DA ,
Invitrogen) at 37°C in a 95% air/5% CO2 incubator for 30 min. Cells were then washed
3X with phosphate buffered saline (PBS) and mounted on the stage of an Axiovert 200
inverted fluorescence microscope. DAF-DA fluorescence was monitored using excitation
and emission wavelengths of 485 and 538 nm, respectively.
BAECs were grown under shear stress and static cells were used as control. After
incubation for 24 hours, media containing 100µM of acetylcholine was injected into the
flow chamber. The cells were incubated again and after 1 hr, 200 uL of media was
withdrawn with a Hamilton gastight syringe and directly injected into the purge vessel of
a Sievers Nitric Oxide Analyzer (Model 280i) which contained acetic acid and sodium
iodide.

Immunofluorescence
BAEC cells were grown on coverslips in 35mm cell culture dishes. The cells were grown
under shear stress for 16 hours and static cells were used as control. After incubation, the
cells were washed with PBS and fixed in 3% paraformaldehyde for 10 min. The cells
were then permeabilized with 0.025% Triton X for 10 min. Rabbit polyclonal antibody
against Ser 1177 phospho eNOS (1:200 dilution; Cell Signal) and anti-mouse caveolin-1
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(1:100) were used as primary antibodies. Alexa Fluor 488 -labelled goat anti-rabbit IgG
and Alexa Fluor 568 conjugated anti-mouse IgG were used as a secondary antibodies
(1:500 dilution; Molecular Probes, Canada). Cells were also stained with either propidium
iodide (PI) or DAPI for the localization of nuclei. Preparations were mounted in
fluoromount G (Southern Biotech) and examined by fluorescence microscopy.

Statistical analysis
Data is expressed as an average of all trials and statistical analysis was done by Student’s
t test. The quantification of the fluorescence intensity was done using Image J software.
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Results
Flow chamber
The parallel plate flow chamber described herein was designed to minimize solution
volumes, to be operationally robust and precise, simple to set up, and inexpensive. Also
critical to the design was the ability of the chamber to be mounted on a microscope stage
to facilitate visualization experiments. The chamber pictured in Figure 1 is 64 mm in
diameter and 28 mm in height. It was machined out of surplus aluminum and acrylic
stock. The unit consists of three principal elements, an inner acrylic “puck” that forms
the chamber, an interchangeable gasket that creates the channel geometry, and an
aluminum clamping fixture that holds it all together. A special low cost thermoset plastic
has been adapted for use as a chamber gasket. A simple series of die punches provide a
variety of channel geometries. The unit can also accept commercially available gaskets
like those produced by Glycotech (Rockville Maryland). Channel depth is set by the
clamping fixture and the thickness of gasket utilized. The two halves of the clamping
fixture thread together to compress the gasket to provide the chamber seal. To ensure
proper channel depth, two interchangeable locator pins prevent the fixture from being
over tightened. Inlet and outlet ports were machined into the top of the acrylic chamber.
Each is threaded to accept standard commercially available fittings.

The ports are

chamfered with a smooth Gaussian shaped profile to minimize flow disturbances during
flow entrance and exit.
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Assembled Chamber
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Figure 1 – Schematic diagram of the parallel plate flow chamber.
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Computational fluid dynamics
To simulate the flow in the chamber and estimate the shear stress for the testing program,
a computational model of the flow channel was developed. The commercial finite volume
solver, Fluent 6.1 was utilized for this study. Free outflow and mass flow inlet boundary
conditions were assumed at the outlet and inlet of the channel respectively in the steady,
laminar simulation. The material properties of the solution were approximated to be that
of water. The inlet/outlet ports and flow channel [19 mm long X 5 mm wide X 0.25 mm
deep] was discretized by tetrahedral elements. Three mesh densities were tested,
consisting of 83,000, 196,000, and 454,000 elements. Values of the flow velocity
assessed at 5 locations across the domain changed by no more than 2% when the mesh
density increased from 196,000 to 454,000. Thus the medium mesh density was chosen
for the test runs.
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A

B

Figure 2 – Velocity gradient template.
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Validation of the flow chamber
In the present study, we first examined the morphological changes of endothelial cells
associated with exposure to physiologically relevant shear stress using this flow chamber.
Bovine aortic endothelial cells were either maintained in static condition or exposed to
laminar flow at a shear stress of 5 dyne/cm2 for 16 h. As shown in Figure 3, fluid shear
stress induced dramatic morphological changes such as cell elongation and alignment
with the direction of flow. In contrast, there is no significant cell orientation in cells under
static conditions.

Control

5 dyne/cm2

Figure 3 – Effect of shear stress on morphology of bovine endothelial cells. Bovine
aortic endothelial cells were maintained either under static conditions or under shear
stress (5 dyne/cm2). After incubation for 16 hours, the morphological changes were
visualized using 20X objective of a Zeiss Axiovert 200 microscope.
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Nitric oxide production and eNOS phosphorylation in response to shear stress
In order to validate whether this flow chamber can be employed for studies in the areas of
biomedical research, the effect of fluid shear stress on nitric oxide production in
endothelial cells was examined. In the present study, nitric oxide production in bovine
aortic endothelial cells was determined by a membrane-permeable fluorescent probe 4, 5diaminofluorescein diacetate (DAF-2 DA). A significant upregulation (~ 3.6 fold) of NO
was observed in endothelial cells which were exposed to laminar flow at a shear stress of
5 dyne/cm2 for 16 hours, compared with those maintained in static condition (Fig. 4 A,
B). A qualitative examination of the data revealed that nitric oxide production increased
by 7 fold as compared to the static cells when the endothelial cells were exposed to a
shear rate of 15 dyne/cm2 (Fig. 4 A, B). A significant upregulation (~ 2.5 fold) of
authentic NO (as determined with NO analyzer) was also observed in endothelial cells
which were exposed to laminar flow at a shear stress of 5 dyne/cm2 for 16 hours,
compared with those maintained in static condition (Fig. 4C).
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Figure 4 – Nitric oxide production and eNOS phosphorylation in response to shear
stress. (A) The bovine endothelial cells grown under static conditions and shear stress
for 16 hours were incubated with 5µM DAF-DA for 30 min. The cells were washed with
PBS and viewed under Zeiss Axiovert fluorescence microscope using 20X objective. (B)
The graph represents average of DAF-DA fluorescence taken from 4 independent
experiments (± SD). *** P < 0.001 (C) Total nitrite was measured in control cells and
cells under shear stress using NO analyzer. The bovine endothelial cells were grown
under shear stress for 16 hours after which the cells were stimulated with acetylcholine
for 1 hour and total nitrite was measured. The data shown is average of 3 independent
experiments (± SD). (D) The cells maintained under static conditions and exposed to
shear stress for 16 hours were fixed with paraformaldehyde and incubated with anti-rabbit
Ser1177 phospho eNOS antibody. Alexa Fluor 488 conjugated anti-rabbit IgG was used
as secondary antibody and the nuclei were stained with PI. The slides were viewed under
oil immersion 40X objective. (E) Average gray values (immunofluorescence intensity) of
phospho eNOS levels in static and shear stress exposed cells. The values (average ± SD)
were calculated from at least 10 different microscopic fields in each slide (n=3). *** P <
0.001.
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Change in caveolin-1 expression after shear stress induction
The changes in caveolin-1 expression and distribution were determined by indirect
immunofluorescence. As shown in Fig. 5, the cells exposed to shear stress showed a ~ 2.7
fold increase in caveolin-1 expression as compared to static cells. In static cells, caveolin1 is present mostly in the plasma membrane, whereas in cells under shear stress caveolin1 is also found in the cytoplasm.

A

Control

5 dyne/cm2

B

Figure 5 – Shear stress upregulates caveolin-1 expression in bovine endothelial cells.
(A) BAECs were exposed to shear stress for 16 hours and static cells were used as
controls. Caveolin-1 expression and distribution (red) was determined by indirect
immunofluorescence. The nuclei were stained with DAPI (blue). The images were taken
by 40X oil emersion objective using Zeiss Axiovert 200 microscope. (B) Average gray
values (immunofluorescence intensity) of caveolin-1 levels in cells maintained under
static and shear stress. The values (average ± SD) were calculated from at least 10
different microscopic fields in each slide (n=3). *** P < 0.001.
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Discussion
Parallel plate flow chambers have been used for years in the study of hemodynamics and
cellular mechanotransduction (Frangos et al 1985; Levesque et al 1985; Galbraith et al
1998; McCann et al 2005; Bacabac et al 2005). The majority of chambers documented in
the literature were developed for specific research applications and were not massproduced for commercial use. The bulk of chambers presently available off the shelf can
cost upwards of $500 for a pump-ready apparatus. They often require the use of a vacuum
line or pump and delicate gaskets to maintain chamber seals and prevent leaks.
This flow device introduced in this study provides a leak proof and contamination
free environment to the cells. It can also be used for real time monitoring of the live cells,
to study the dynamics of endothelial cell response to shear. The materials used for making
this flow device are chemical resistant. Advantages of this system include its simplicity of
use and small number of cells required to run a simulation. The fabrication is convenient,
versatile and economical.
The reorganization of the endothelial cell morphology is one of the earliest
responses in the endothelial cells that are exposed to fluid shear stress. Previous in vivo
and in vitro studies have shown that the endothelial cells elongate and align parallel to the
direction of flow (Azuma et al 2001; Wojciak-Stothard et al 2003). Our results also
showed change in morphology of the endothelial cells, which are in agreement with the
previous reports by other groups (Topper et al 1999; Wang et al 2001; Kadohama et al
2006).
Shear stress is one of the most important physiological stimuli which modulate
many physiological and pathological processes associated with endothelium, such as
inflammatory response, vasodilation and endothelial cell proliferation (Davies et al 1995).
It acts as a potent stimulus for endothelium-dependent NO production and vasodilation
(Kuchan et al 1994).
An important step in the validation process was to determine whether our flow
chamber was able to discern different shear rates. BAECs were exposed to two different
shear rates (5 & 15 dyne/cm2) and changes in NOx production in response to shear stress
were determined. There was a ~ 3.5 fold increase in NOx production at 5 dyne/cm2 and a
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7 fold increase at 15 dyne/cm2 as compared to the static cells. These results suggest that
this flow chamber can be utilized to attain different shear rates. These findings are also in
agreement with numerous previous studies which demonstrated nitric oxide upregulation
in response of laminar shear stress (Andrews et al 2010; Yang et al 2007).
Previous studies have shown that increase in shear stress increases eNOS activity
by phosphorylation of eNOS at serine 1177 (Corson et al 1996; Dimmeler et al 1999).
The results of this study also illustrated increase in phosphorylation of eNOS at Ser 1177
by 2.3 fold.
Caveolae are small cell surface plasma membrane invaginations, which have
important role in cell signaling and cholesterol homeostasis. Cholesterol binding protein
caveolin-1 is the main marker of caveolae. Caveolin-1 could mediate the transfer of
newly synthesized cholesterol from the ER to the plasma membrane (Smart et al 1996).
Our results are also in agreement with a previous study which has shown that laminar
shear stress increases caveolin-1 expression and it also changes the localization of
caveolin-1 (Sun et al 2002).

Conclusions
In conclusion, we have introduced a parallel plate flow chamber for shear stress studies in
vitro. The data provides robust evidence that this parallel plate flow chamber can be used
as an effective in vitro system to study the effects of fluid shear stress on the structure and
function of endothelial cells. The flow rates can be precisely controlled in this laminar
flow chamber to induce normal stress and shear stress so as to simulate the hemodynamic
environment of human arteries in vivo.
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CHAPTER 3

Real-time kinetic analysis of platelet function in a flow
chamber with matrix proteins covalently attached onto a
polydimethylsiloxane surface.
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Introduction
Platelet adhesion and aggregation is the first step in the physiological defence mechanism
of the body in blood vessel injury. Exposure of extracellular matrix at the sites of sub
endothelial disruption leads to the capture of platelets to the matrix through various
receptors including GPIb-IX-V and GPVI, resulting in platelet activation, followed by
thrombi formation. Shear forces generated by blood flow play an important role in
platelet adhesion and hence vascular hemostasis.
Several investigations on platelet function have focused on the platelet adhesion to
various matrices (fibrinogen, collagen) under flow conditions. In all of these studies, glass
slides are coated with fibrinogen, collagen or vWF etc (Turner et al 2001; Remijn et al
2002) and then used to study platelet aggregation mechanisms. Numerous devices
including parallel plate flow chambers, which mimic the in vivo conditions (Goncalves et
al 2003), are available for platelet aggregation studies under various physiological
conditions. Some of these flow devices and microfluidic devices have been custom
laboratory prototypes, while others are commercially available. There is currently little to
no availability of simple, reliable, robust, and inexpensive flow chambers for use in
kinetic aggregation studies.
Table 1 – Devices available to study platelet aggregation in vitro.

Device

Advantages

Disadvantages

Kinetic/Static

Cone and plate High shear rates can
viscometer
be attained
Parallel plate flow Easy to use and
chamber
manufacture,

Real time analysis Static
not possible
Cannot be easily Kinetic
modified, requires
sizable volumes of
reagents
Microfluidic devices Real time imaging, Costly
Kinetic
less sample volumes
and cells required
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In the present study, we describe the construction and testing of a parallel plate flow
chamber, which fits onto an inverted microscope and permits the optical monitoring of
the binding of fluorescently-labelled platelets, in whole blood, onto platelet-binding
proteins covalently attached to a small area (~0.8 mm2) on the flow-device’s surface
under in vivo-like conditions. The flow device was validated by comparing the kinetics
of adhesion of resting as well as Ca2+- and ADP-activated platelets from normal and type
2 diabetic subjects onto fibrinogen and collagen covalently attached to the flow devices.
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Experimental methods
Subject selection
Healthy human subjects (n=5), ages 25-40 years were chosen to participate in the study
only if they showed no overt symptoms of disease and were taking no medication.
Diabetic human subjects, ages 25-40 (n=5) on diet therapy alone and achieving stable and
satisfactory glycemic control (fasting glycemia and glycosuria variation <15%; postprandial glycemia variation<25% and HbA1c<7.5%) were chosen for inclusion in the
study. None of the patients smoked, had history of alcohol abuse or were taking insulin or
any drugs known to lower lipids or interfere with the coagulation and antioxidant
systems. The experimental protocols were approved by the University of Windsor
Research Ethics Board.

Construction of flow chamber
The flow chamber consisted of a Teflon boundary sealed with 1.5cm microscope
coverslips (Figure 1 A). The walls of the flow cell were made of polydimethylsiloxane
(PDMS) (Sylgard 184, Dow Corning). A layer of PDMS, ~ 0.96m thick, was poured on
the bottom of the chamber.

Plasma Oxidation of PDMS
To generate silanol groups on inert PDMS (Miyaki et al 2007) (Figure 1 B), plasma
oxidation was carried out using a Plasma cleaner PDC-32G (Harrick Plasma, USA).

Protein immobilization chemistry
After plasma oxidation, 0.2µl of 2% aminopropyltrimethoxysilane (APTMES) (Sigma,
Canada) was added on ~1 mm2 surface of PDMS, in the centre of the flow chamber. After
10 minutes, a 0.5 µl portion of 0.5mM disuccinimidyl suberate (DSS) (Pierce, USA)
solution and 5M of Type I fibrinogen from bovine plasma (Sigma) solution was added
to the APTMES dot in the geometrical centre of the flow chamber. For the experiments
with collagen immobilization, 8M of collagen type I from rat tail (BD Biosciences) was
used. The reaction was stopped after 15 minutes by adding Tris buffer pH 8. The
immobilization chemistry is shown in Figure 1 B.
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Aminolysis of succinimidyl group
DSS has N-hydroxysulfosuccinimide (NHS) esters at each end and during the
crosslinking reaction of DSS with primary amines, succinimidyl group is aminolyzed and
released. The kinetics of the crosslinking reaction was determined by changes in
absorption by succinimidyl group at 260 nm. The reaction was performed in Tris buffer
(pH 8) with aminosilane alone, aminosilane and DSS, fibrinogen only, fibrinogen and
DSS, collage only or collagen and DSS. All measurements were taken using Agilent 8453
UV-Visible spectrophotometer.

FITC-Fibrinogen labelling and standardization of cross linking time
Fibrinogen was incubated with fluorescein-isothiocyanate (FITC) at room temperature for
2 h in the presence of 1 M bicarbonate buffer pH 9.0. The labelled fibrinogen was run
over G25 column in the dark to remove unbound FITC. Protein concentration was
determined by bicinchoninic acid (BCA) assay. Aminosilane was added to plasma
oxidized PDMS surface as described earlier. FITC-fibrinogen was added onto
aminosilane either with DSS or after 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 sec of DSS
addition. After 15 min incubation in dark, excess fibrinogen was washed off with Tris
buffer and the bound FITC-fibrinogen was detected by Zeiss Axiovert 200 fluorescence
microscope.

SDS washing of immobililized fibrinogen
Fibrinogen was fluorescently labelled with FITC and immobilized on PDMS by the
method described above. Fibrinogen-FITC adsorbed on PDMS was used as a control.
This was followed by addition of 2% SDS and the samples were incubated in dark for 3
hours. After incubation, the PDMS surface was washed with PBS and images were taken
using Zeiss Axiovert 200 fluorescence microscope.
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Blood collection and washing of platelets
Platelets were isolated as described previously (Miersch et al 2007) and were labelled
with 60 μM BODIPY® FL N-(2-aminoethyl) maleimide (Molecular Probes, Canada).
After 30 min incubation, platelets were washed twice with HEPES-ACD buffer to remove
the excess dye and were put back into whole blood.

Light transmission platelet aggregometry
HEPES ACD was added to BODIPY® FL N-(2-aminoethyl) maleimide labelled and
unlabelled platelets to get a final concentration of 1 X 107 platelets/mL. 5µM ADP was
added as an agonist after ~ 40 sec. The platelet samples without ADP were used as
controls. The kinetics of the aggregation reaction were determined by measuring
absorbance at 600 nm for 5 min.

Perfusion studies in flow chambers
The flow cell circuit used for this investigation consists of a custom designed flow
chamber, PTFE Teflon sterile tubing (0.031” X 0.062”), a medium reservoir, and a
peristaltic pump (Reglo Digital MS 4/6, model ISM 833, Ismatec).

Statistical analysis
Data is expressed as an average of all trials and statistical analysis was done by student’s t
test.
Chemical structures in Figure 1 were drawn with ChemDraw 11.0 (Cambridge Software).
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RESULTS
Flow chamber geometry and immobilization chemistry
The conventional flow chambers test platelet adhesion and aggregation by coating
fibrinogen/collagen on glass slides. In the present study, we plasma-activated an
otherwise inert matrix PDMS and used a bifunctional, primary amine-directed crosslinker
DSS, to immobilize platelet-binding proteins on the PDMS surface (Figure 1B).
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Figure 1 – (A) Geometry of the flow chamber used for perfusion studies. (B) Chemistry
of immobilizing fibrinogen and collagen on PDMS. Hydroxyl groups were formed on
inert and hydrophobic PDMS by plasma oxidation. Coating of APTMES on polymer
surface after plasma oxidation resulted in an amine terminated surface layer. DSS was
used as a bi-functional crosslinker which reacts both with the amine terminated surface
layer and with the amine groups of the proteins to be immobilized.

76

Velocity profile

Figure 2 – Velocity profile. The graph shows the velocity profile from the inlet to the
two different points in the centre of the flow device. The velocity of flow is zero in the
boundary layer and rises monotonically with distance z from the wall, reaching maximum
at the centre. Z/Zr is the ratio of distance at a given point to the distance to the centre.
Vy/Vym is the ratio of the velocity at a given point to the velocity at the centre.
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Crosslinking reaction between fibrinogen/collagen/aminosilane and DSS
DSS is a homobifunctional crosslinker which has amine reactive NHS esters at both ends.
It reacts with primary amines in slightly alkaline conditions to yield stable amide bonds.
This aminolysis reaction releases N-hydroxysuccinimide, which has an absorption
maximum at 260 nm. The aminolysis reaction between collagen and DSS and fibrinogen
and DSS is shown in Figure 3 A and B respectively.
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Figure 3 – Kinetic data for aminolysis of DSS. Aminosilane, fibrinogen and collagen
were diluted in Tris buffer (pH 8) in different cuvettes. DSS was added after ~ 150 sec
and kinetics was measured at 260 nm using UV-Vis spectrophotometer (n=3). Samples
without DSS addition were used as controls.

79

Variations in time point at which fibrinogen/collagen is added to DSS affects
immobilization.
Since DSS is a homobifunctional crosslinker, if we add fibrinogen at a later point, all of
DSS might react with aminosilnae leading to less protein immobilization. To ensure
complete immobilization of fibrinogen onto PDMS surface, the time point at which
fibrinogen should be added to DSS has to be determined. FITC labelled fibrinogen was
added onto the DSS either with DSS or at different time points. The fluorescence was
maximum when DSS and fibrinogen were added together to aminosilane. There was no
fluorescence detected when only fibrinogen was added on PDMS surface without any
immobilization chemistry.
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Figure 4 – Variations in time point at which fibrinogen/collagen is added to DSS
affects immobilization. (A) The images show FITC-fibrinogen immobilized on PDMS
surface where it was added onto aminosilane and DSS at varying time intervals. (B) The
bar graph shows average fluorescence intensity for FITC-fibrinogen fluorescence, where
each bar represents the mean ± SD from at least three independent experiments.
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SDS washing of FITC-fibrinogen
Due to the hydrophobic nature of PDMS, it shows high affinity for proteins. In order to
show that the proteins (fibrinogen/collagen) are covalently linked and not adsorbed, the
PDMS surface was treated with SDS. Figure 5 illustrates that SDS washes off the protein
while about 90% of the protein remains on the PDMS-AS-DSS-Fib surface.

Figure 5 – SDS washing of FITC-fibrinogen. Fibrinogen was labelled with FITC and
immobilized on PDMS surface. The surface was incubated with 2% SDS for 3 hours and
was washed with Tris buffer. After 3 hours, the covalently linked protein was still there
whereas the control showed almost no protein left (n=3).
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Effect of bodipy labelling on platelet aggregation
The platelets were fluorescently labelleled with BODIPY FL N-(2-Aminoethyl)
maleimide for the further experiments. To analyze the effects of the fluorescent label on
platelet aggregation, light transmission aggregometry was done using UV-Vis
spectrophotometer. Absorbance at 600 nm was monitored for labelled and unlabelled
platelets in the presence and absence of ADP. As can be seen from the optical assessment
of aggregation shown in Fig. 6, bodipy-modification at the levels we employ does not
interfere with ADP-induced aggregation.
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Figure 6 – Effect of bodipy labelling on platelet aggregation. The platelets were
diluted in HEPES ACD and 5 µM ADP was added as an agonist after ~ 40 sec. The
decrease in absorbance indicates platelet aggregation. The platelets without ADP addition
were used as control.
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Validation of the flow chambers
In order to assess the suitability of the flow chamber and the immobilization chemistry for
platelet adhesion studies, adhesion to collagen and fibrinogen was tested. Flow chambers
were placed onto an inverted fluorescence microscope (Zeiss Axiovert 200M. Whole
blood containing fluorescently labelled platelets was perfused over the flow chambers
containing either PDMS alone or PDMS-immobilized BSA or fibrinogen or collagen. The
perfusion rate was 2 ml/min, which generates shear equivalent to that of descending aorta
(5 dyne/cm2). The platelets were either activated by the injection of Ca2+ (1 mM) or ADP
(20 µM) at t=0. The raw image data, at 40 s intervals, is presented in Figure 7. With the
controls, PDMS alone or PDMS-immobilized BSA, there were <50 platelets attached
after 200 s of perfusion (Figure 7).
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Figure 7 – Comparison of platelet aggregation in normal and type 2 diabetic
subjects. Whole blood containing fluorescently labelled platelets was passed over PDMS
alone and PDMS with immobilized BSA, fibrinogen (Fib) or collagen (Coll) using either
1 mM calcium (Ca2+) or 20 µM ADP as activators. The images show time dependent
increase in platelet adhesion to fibrinogen and collagen, with very little adhesion to the
controls (PDMS and BSA). The total number of adherent platelets after 200 sec is greater
in the case of type 2 diabetic (T2D) subjects as compared to normal (N) subjects,
irrespective of the protein/activator used. All experiments were done at 37oC. Images
were captured in 20 sec intervals by Zeiss Axiovert 200 microscope with achromat 5X
objective (Carl Zeiss), equipped with a Retiga EX cooled monochrome 12 bit camera (Q
imaging) and an Xcite series 120 (EXFO,Canada) mercury lamp. Image capture and the
quantification of the adhered platelets were facilitated by Northern Eclipse software
(Empix, Canada).
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Kinetic plots of platelet aggregation
Images over the immobilized protein (fibrinogen or collagen) field were captured every
20 s. The platelets were counted in each frame using Northern Eclipse software and the
kinetic plots were constructed (Figure 8). There is an increased rate of platelet
aggregation in diabetic subjects as compared to the controls.

Figure 8 – Kinetic plots of platelets adhered to immobilized fibrinogen and collagen
over time. Blood reconstituted with fluorescently labelled platelets from normal and
diabetic subjects was perfused through the flow chambers containing immobilized
fibrinogen and collagen. Graphs (i) and (ii) show platelets adhered to collagen and
fibrinogen, respectively, over time, when calcium was used as an activator. Graphs (iii)
and (iv) show increasing number of platelets adhered to collagen and fibrinogen
respectively, when ADP was used as an activator. The number of platelets adhering over
time is greater in diabetic subjects (squares) as compared to normal subjects (triangles).
The platelet binding data is extracted from the entire image data set taken at 20 sec
intervals. Each point represents the mean ± SD from at least three independent
experiments. The solid lines represent the best fit line for the first order treatment of the
binding data: Y=A (1-e-kt).
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The total number of platelets bound to the protein surfaces are summarized in Table 1. In
general, the maximum number of platelets bound at saturation (~200 s) was larger for
platelets from T2D subjects in comparison to those from the normal subjects, under all
conditions examined. The largest ratio between T2D to normal of ~1.73 was obtained
with Ca2+-activated platelets on a fibrinogen surface. The smallest ratio of ~1.31 was
obtained with ADP-activated platelets on a collagen surface.

Table 1 – The table shows the total number of normal and type 2 diabetic (T2D) platelets
± SD attached to fibrinogen (Fib) and collagen (Coll) after 200 sec, with calcium (Ca2+)
and ADP as activators.

88

Table 2 – The first order rate constants were calculated from the kinetic plots of the
platelet adhesion data. The T2D platelets have higher rate constants as compared to the
normal (*P<0.05).
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Discussion
The novel aspect of this study is the surface chemistry, which can be utilized for facile
patterning of immobilized proteins on PDMS surface. The design of the flow device and
immobilization chemistry introduced here can easily be adapted to microfluidic/lab on
chip applications for the analysis of hemostasis. The glass coverslip on the bottom of the
flow chamber can be removed, which allows for cheap and reproducible flow chambers
for further experiments.
The washing of PDMS with SDS could not remove the immobilized fibrinogen.
This indicates that AS-DSS can bind protein more tightly than physiosorption. Light
transmission aggregometry illustrated that platelet labeling with Bodipy does not affect
the aggregation of platelets in response to agonists’.
When the whole blood was passed over fibrinogen or collagen coated flow
devices there was a continuous build up in the adhered platelets over the initial density
pattern established in the previous time frames indicating that the interaction was
irreversible. At the end of the binding experiments ~10 mL of buffer was pumped through
the flow chambers. The number of adhered platelets did not change, which was a further
indication of the irreversibility of the interaction with protein matrices covalently attached
to the PDMS surface. One observation from the kinetic plots of the data was that when
platelets were activated with Ca2+, with either on the collagen or the fibrinogen surface,
there was a 20 s to 40 s lag prior to the initiation of platelet binding irrespective of the
platelet source (T2D or normal) (Figure 8 i, ii). In contrast, this lag was absent in the
ADP-activated platelets (Figure 8 iii, iv).
It is well established that in T2D, the platelets have altered in vitro adhesion and
aggregation patterns and are hypersensitive to agonists as compared to the normal
platelets (Glassman et al 1993; Dittmar et al 1994; Haouari et al 2008; Vinik et al 2001).
Therefore, an important step in the validation process was to determine whether our flow
devices were able to discern functional differences between platelets from normal and
T2D subjects. To this end, we compared the adhesion kinetics of Ca2+ or ADP activated
platelets from control and T2D subjects onto immobilized collagen and fibrinogen in the
flow chambers. A qualitative examination of the raw data (Figure 7) revealed that
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platelets from T2D subjects gave rise to more platelet adhesion irrespective of the
activator used or the immobilized surface.

These observations were elegantly

substantiated upon kinetic treatment of the data (Fig 8 i to iv and Tables 1 and 2).
The rate constants extracted from first order kinetic treatment of the data (Table 2)
revealed that the binding rate constants for platelets from normal subjects were in general
independent of the activator used or the protein immobilized since the differences
between the rates (0.014  0.002 sec-1) were not statistically significant. However, when
the rate constants of the various activator/protein surface combinations from T2D were
compared to normal, in all cases the T2D gave rise to 1.12-fold to 1.33-fold larger and
statistically significant, platelet-binding rate constants (0.018  0.002 sec-1).

Conclusions
In conclusion, here we have introduced a simple and robust method for the construction
of flow cells made out of PDMS as well as the chemistry for the covalent attachment of
any platelet-reactive peptides or proteins onto the PDMS surface. We have also
demonstrated that the flow cells can readily provide real time data on the kinetics of
platelet binding and can detect subtle pathological changes in platelet function introduced
as a result of pathologies such as type 2 diabetes.
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CHAPTER 4
Whole blood, flow-chamber studies in real-time indicate a
biphasic role for thymosin β-4 in platelet adhesion

Published as original research as Kaur et al. 2010
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Introduction
Thymosin β4 (Tβ4) is a water-soluble, ubiquitous, highly conserved 43-amino acid acidic
polypeptide (pI 5.1) with a molecular weight of 4.9 kDa (Low et al 1981, 1982; Yu et al
1994; Goodall et al 1983, 1983). It was originally isolated from the thymus but is present
in different concentrations in different tissues, cell types and extracellular fluids (blood,
plasma, saliva, tears). It is found at concentrations of ~5 nM to ~80 nM in plasma to ~500
μM in platelets (Hannappel et al 1982, 1985, 1987; Huff et al 2001). Tβ4 lacks a
secretion signal and hence its presence in extracellular fluids could be due to cellular
damage.
The major intracellular function of Tβ4 in mammalian cells is to form a 1:1
complex with G-actin, preventing its polymerization (Low et al 1981; Hannappel et al
1985; Safer et al 1991). Apart from its interactions with actin, Tβ4 is capable of
modulating a wide array of biological functions including tissue (Goldstein et al 2005)
and wound repair (Sosne et al 2002) as well as anti-inflammatory (Young et al 1999)
antiapoptotic and neurotrophic (Sun et al 2007) properties. Tβ4 has been also shown to
play a relevant role in angiogenesis (Smart et al 2009) and neural development (Lin et al
1990). It also protects the cells against oxidative damage and upregulates anti-oxidative
enzymes catalase and SOD (Ho et al 2008). The role of Tβ4 in increasing hair growth and
dermal repair has also been studied, where it promotes stem cell migration and their
subsequent differentiation into keratinocytes and hair follicles (Philip et al 2004).
The ability of Tβ4 to affect these diverse biological functions has been ascribed to
an array of short, bioactive, peptide sequences within the Tβ4-primary sequence (Sosne et
al 2010) (Fig. 1).
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Figure 1 – Location and activity of different peptides derived from Tβ4 (Image
taken from Sosne et al 2010).
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The largest concentrations of Tβ4 are found in leukocytes and platelets (Low et al 1981;
Yu et al 1994; Goodall et al 1983; Hannappel et al 1985, 1987). In resting platelets, it has
been estimated that ~60% of the actin is prevented from polymerizing by complexing
with Tβ4 (Fox 1993). Upon platelet activation, Tβ4 is secreted and cross-linked
enzymatically by factor XIIIa (a transglutaminase) to fibrin in a time- and Ca2+-dependent
manner (Huff et al 2002; Makogoneko et al 2004) thus increasing the local concentration
of Tβ4 near sites of clots and tissue damage, where it is postulated to contribute to wound
healing, angiogenesis and inflammatory responses. Platelets carry and release large
amounts of Tβ4. Yet the role of Tβ4 on platelet thrombus formation has yet to be fully
investigated. The current study represents a small step towards this goal. Here, we have
tested the effects of Tβ4 extraneously added to whole blood, on deposition of ADP
activated platelets onto fibrinogen under conditions of continuous flow and shear.
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Experimental methods
Subject selection
Healthy human subjects (n=5), ages 25–40 years were chosen to participate in the study
only if they showed no overt symptoms of disease and were taking no medication. The
experimental protocols were approved by the University of Windsor Research Ethics
Board.

Construction of the flow chamber
The flow chamber consisted of a Teflon boundary with matching holes (1.75mm) drilled
through sides a and b (Fig. 2A). The Teflon boundary was first attached onto 1.5 cm
microscope coverslips by painting a small amount of Sylgard 184 (trade name of
polydimethylsiloxane- PDMS), (Dow Corning) base plus curing agent (mixed in a 10:1
ratio). Teflon® tubing (2 cm) was then inserted through the holes and enough Sylgard
184, (Dow Corning) base plus curing agent was poured to fill the mold. After curing for 6
h at 60 °C the Teflon tubing was removed by pulling through the holes (sides a or b, Fig.
2A). The flow chamber was then placed into a plasma cleaner PDC-32G (Harrick Plasma,
USA) in order to generate silanol groups (Miyaki et al 2007) on the otherwise inert
PDMS-walls of the flow chamber (Fig. 2B).

Protein immobilization onto plasma activated PDMS surfaces in the flow chambers
After plasma oxidation, 5 μl of 2% aminopropyltrimethoxysilane (APTMES) (Sigma,
Canada) was added to the geometric centre of each of the flow channel with the aid of a
Hamilton syringe. After 10 min, a 0.5-μl portion of 0.5 mM disuccinimidyl suberate
(DSS) (Pierce, USA) solution was added to the APTMES ring at the centre of the flow
channels. Within 30 s of DSS addition, either 1 μl of either Type I fibrinogen (5 μM)
from bovine plasma (Sigma-Aldrich, Canada) or of collagen type I (8 μM) from rat tail
(BD Biosciences) was introduced into the reaction mixture. The reaction was stopped
after 15 min by pumping 10 mL of Tris–HCl buffer (0.15 M, pH 8.0) at a rate of 2 ml/min
through the flow chamber.

97

Blood collection and washing of platelets
Platelets were isolated as described previously (Miersch et al 2007) and were
fluorescently labelled by reacting for 30 min, with 60 μM BODIPY® FL N-(2aminoethyl) maleimide (Molecular Probes, Canada). The labelled platelets were
harvested by 2 centrifugation-wash (HEPES-ACD buffer) steps to remove the excess dye
and were reintroduced into the whole blood sample that they were originally isolated
from.

Monitoring platelet deposition via flow cells
A flow cell with the coverslip face-down was placed in the turret of a Zeiss Axiovert 200
M inverted fluorescence microscope equipped FITC filter cube, and 5×objective.
Fluorescence images were captured at 20-s intervals with the aid of a CCD camera
(Hitachi KP-F140F). Two syringe pumps (New Era Pumps, NE-300) were utilized to mix
the activating agent (ADP, 400 μM/ Ca2+, 100mM; flow rate 0.05 mL/min) with the
whole blood containing the fluorescently-labelled platelets (flow rate 0.95 mL/min) at a tjunction. This yields final Ca2+ and ADP concentrations in the flow cell of 5 mM and 20
μM, respectively. At the start of the experiment only the blood was pumped through the
channel to adjust the focus and to optimize image capture parameters. At t=0 the
activating agent pump was started and image capture initiated. A given blood sample was
pushed separately though each flow channel thus generating 4 sets of binding data per
sample. The estimated shear on the wall of the flow cells was 150 s−1 (5 dyne/cm2), which
represents shear rate in the descending aorta or veins. Image analysis was performed with
the aid of Northern Exposure 6.0 (Empix, Mississauga, ON) and ImageJ
(NIH) imaging software packages.
Tβ4 binding assay
A 96-well plate was filled with 50 μL of PDMS at a ratio of 10:1, base: curing agent.
Fibrinogen was immobilized on PDMS as described before. Tβ4 was labelled with eosinisothiocyanate (EITC) at room temperature for 2 h in the presence of 1 M sodium
bicarbonate buffer pH 9.0. The labelled Tβ4 was run over a G25 column in the dark to
remove unbound EITC. Protein concentration was determined by bicinchoninic acid
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(BCA) assay. Tβ4 was added to the wells at concentrations of 0.1 μM, 0.2 μM, 0.5 μM, 1
μM, 2 μM and 4 μM. In some wells, unlabelled 4 μM Tβ4 was also added. For control,
labelled Tβ4 was added to the activated PDMS alone. The plate was incubated under
gentle agitation for 2 h in the dark. Fluorescence was monitored in the solution before and
after incubation by Cary Eclipse Fluorescence Spectrophotometer with excitation at 520
nm and emission at 540 nm. To study the thymosin beta 4 binding to fibrinogen under
flow, fibrinogen was immobilized in the flow chamber (i.e. the yellow region Fig. 1A)
and excess eosin-Tβ4 was introduced onto the fibrinogen. The flow chamber was then
washed with PBS to remove excess eosin-Tβ4. Increasing concentrations of unlabelled
Tβ4 (10 nM–1 μM) were pumped through the flow cells with a syringe pump (New Era
Pumps, NE-300) at a rate of 1.0 mL/min and 0.2 mL fractions were collected using a
fraction collector (Bio-Rad, Model 2110). Fluorescence was monitored in the fractions by
Cary Eclipse Fluorescence Spectrophotometer with excitation at 520 nm and emission at
540 nm.

Statistical analysis
Data is expressed as an average of all trials and statistical analysis was performed by
Student's t-test the error bars represent s.d. Chemical structures in Fig. 1 were drawn with
ChemDraw 11.0.
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Results
Flow chamber geometry and immobilization chemistry

Figure 2 – Geometry of the flow chamber and chemistry used for immobilizing
fibrinogen/collagen in the flow chamber.
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Validation of the flow chambers
In these studies, the raw image files collected at 20 s intervals were converted to 8-bit
gray scale images. We then used the ImageJ plugin, Multi Otsu Threshold introduced by
Dos Santos et al. (Santos et al 2009) to ensure that we did not count the platelets that
were transiently associated with the immobilized proteins (appear as streaks in the raw
images: indicated with arrows in Fig. 3). Otsu multi-thresholding eliminated the streaks as
well as the out of focus platelets deposited on the edges (see Fig. 2 a, b, c, d, e vs. a', b', c',
d', e'). The processed-images were subsequently counted by using ImageJ: Step 1
menu>image>adjust>threshold; and Step 2—Menu>analyze>analyze particles.
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Figure 3 – Demonstration of the Otsu Multi-Thresholding ImageJ plugin to exclude nondeposited, transiently associated platelets from being counted in the deposition data.
Representative raw images obtained at 120 s in flow cells with immobilized BSA, a;
immobilized collagen with Ca2+ as activator, b; immobilized collagen with ADP as
activator, c; immobilized fibrinogen with Ca2+ as activator, d; immobilized fibrinogen
with ADP as activator, e. The same Images after Otsu Multi Thresholding with
immobilized BSA, a'; immobilized collagen with Ca2+ as activator, b'; immobilized
collagen with ADP as activator, c'; immobilized fibrinogen with Ca2+ as activator, d';
immobilized fibrinogen with ADP as activator, e'. Arrows point to non deposited platelets
appearing as streaks.
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Platelet deposition on collagen/fibrinogen in the presence of Ca2+/ADP
A representative set of platelet deposition data from blood samples isolated from the same
subject, exposed to the either Ca2+ or ADP as activator with either BSA or fibrinogen or
collagen immobilized into the flow cell surfaces is presented in Fig. 4 A – F. The platelet
deposition data for collagen and fibrinogen were well accommodated by a first order
kinetic process [# of platelets deposited at a given time (t) =Maximum # of platelets
deposited*(1- e−kobs*t)]. The rate constants estimated from first order kinetic treatment of
the data revealed that the rate of platelet deposition was independent of both the activators
used (Ca2+ or ADP) and the protein immobilized (collagen or fibrinogen) since the
differences in the rates obtained under the various conditions were not statistically
significant (Fig. 4G). This same trend was observed with all subjects tested (n=5).
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Figure 4 – Kinetic plots obtained from particle counts of Otsu Multi Threshold images
for platelets deposited onto immobilized BSA, A; immobilized collagen with Ca2+as
activator, B; immobilized fibrinogen with Ca2+ as activator, C; immobilized
fibrinogen/collagen without any activator, D; immobilized collagen with ADP as
activator, E; immobilized fibrinogen with ADP as activator, F; (n=4 from a single
subject). Composite rate constants: an average rate constant from each subject was
obtained by performing the deposition experiment under each condition (A to F) in
quadruplicate. The average value for each condition was then averaged for all the subjects
(n=4), G. Composite # of deposited platelets: an average # of deposited platelets from
each subject were determined from the 120 s images by performing the deposition
experiment under each condition (A to F) in quadruplicate. The average value for each
condition was then averaged for all the subjects (n=4), H. The solid lines represent the
best fit line for the first order treatment of the binding data: Y = A (1- e−kt). Error bars
represent s.d.
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The effect of Tβ4 on platelet deposition under conditions of flow.
The flow system was then employed to test the effect of Tβ4-dose on the deposition of
ADP-activated platelets to fibrinogen immobilized flow cells. In these studies, Tβ4, at the
concentrations indicated (Fig. 5) was incubated for 15 min with the blood/fluorescently
labelled platelet mixtures before the deposition experiments were carried out. As can be
seen from the kinetic binding data (Fig. 5A) and a representative data set of the images
captured at 120 s from the blood samples obtained from the different subjects (S1 to S4,
Fig. 5B), Tβ4 had a biphasic effect on both the rates of deposition as well as the number
of platelets deposited. Above a critical concentration of ~0.2 μM Tβ4 the platelet
deposition is not uniform over the flow cell surface as observed in the control or the
validation experiments (Fig. 3 and 4). Instead, large thrombi are evident indicative of
platelet–platelet interactions. These are reflected in the ~4-fold increase in the estimated
number of platelets deposited (Fig. 5D). The estimated rate constants of platelet
deposition also increased ~1.5-fold during this process.
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Figure 5 – The effect of Tβ4-dose on the rate and density of platelet deposition.
(A) Kinetic plots obtained from particle counts of Otsu Multi Thresholded images for
platelets deposited on immobilized fibrinogen with ADP as activator, as a function of
Tβ4-dose. The solid lines represent the best fit line for the first order treatment of the
binding data: Y = A (1- e−kt). Error bars represent s.d. (n=4). (B) Representative raw
images from each subject (S1 to S4) at 120 s as a function of Tβ4-dose. (C) Composite
rate constants: an average rate constant from each subject was obtained by performing the
platelet deposition as a function of Tβ4-dose, in quadruplicate. The average value for
each [Tβ4] was then averaged for all the subjects. Error bars represent s.d. (n=4). (D)
Composite # of deposited platelets: an average # of platelets deposited from each subject
was determined from the 120 s images as a function of Tβ4-dose, in quadruplicate. The
average value for each [Tβ4] was then averaged for all the subjects. Error bars represent
s.d. (n=4).
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Tβ4 binding to immobilized fibrinogen
The decrease in platelet aggregation in the presence of high concentrations of Tβ4
suggests that Tβ4 might be binding with fibrinogen and hence inhibiting fibrinogen
mediated platelet aggregation. This led us to propose this hypothesis that Tβ4 might have
a binding site on fibrinogen. In order to test our fibrinogen binding hypothesis, we
immobilized fibrinogen onto PDMS on the bottom of 96-well plates using the same
chemistry as in the flow cells (Fig. 1). We then used a fluorescent Tβ4 derivative, eosinTβ4, to perform equilibrium binding studies. In these experiments increasing amounts of
eosin-Tβ4 were added to either activated PDMS (Fig. 6A, diamonds) or PDMSfibrinogen (Fig. 6A, triangles) or PDMS-fibrinogen containing a constant amount of
unlabelled Tβ4 (Fig. 6A, circles). There was only significant Tβ4-binding to fibrinogen
immobilized PDMS and not to PDMS alone or when labelled Tβ4 was added to PDMSfibrinogen in the presence of a constant amount of unlabelled Tβ4. These experiments
indicate that we are observing a specific interaction between fibrinogen and eosin-Tβ4.
The KD estimated for this interaction was ~126±18 nM (i.e. negative reciprocal of the
slope of the Scatchard plot of the binding data, Fig. 6B).We also estimated the Tβ4fibrinogen interaction under flow. To do this, excess eosin-Tβ4 was introduced onto the
fibrinogen immobilized in the flow chambers (i.e. the yellow region Fig. 2). The excess
eosin-Tβ4 was removed by pumping 2 mL of PBS over the flow cells. Next increasing
amounts of unlabelled Tβ4 was pumped through the flow cells with a syringe pump at a
rate of 1.0mL/min and 0.2 mL fractions were collected. The total fluorescence (eosinTβ4) summed over fractions 1 and 2 was plotted against unlabelled [Tβ4] (Fig. 6C). The
data were fitted to the competitive binding equation Eq. (1)
100% (total fluorescence) - % fluorescence eluted f ([½Tβ4])) =
[eosin−Tβ4]
KD-eosin−Tβ4 (1 + [Tβ4]/ KD-Tβ4 ) + (eosin−Tβ4)
where KD− eosin-Tβ4 = the dissociation constant between fibrinogen and eosin-Tβ4; and KD−
Tβ4 = the dissociation constant between fibrinogen and unlabelled-Tβ4. The KD−

Tβ4

estimated under flow conditions was 66±20 nM.
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Figure 6 – Binding of eosin-Tβ4 to fibrinogen immobilized on PDMS.
(A) Equilibrium binding of eosin-Tβ4 to fibrinogen. Increasing amounts of eosin-Tβ4
were added to activated PDMS (diamonds) or PDMS-fibrinogen (triangles) or PDMSfibrinogen containing a constant amount, 4 μM, of unlabelled Tβ4 (circles). Bound eosinTβ4 fluorescence = total eosin-Tβ4 fluorescence−free eosin-Tβ4 fluorescence (i.e.
fluorescence of the supernatant after addition onto PDMS-wells) as a function of eosinTβ4-dose. Error bars represent s.d. (n=5). (B) Scatchard plot of the binding data.
KD=−1/slope. Error bars represent s.d. (n=5). (C) Binding of eosin-Tβ4 to fibrinogen
under flow. Increasing concentrations of unlabelled Tβ4 were pumped over the flow cell
containing immobilized fibrinogen and eosin-Tβ4. The total fluorescence (eosin-Tβ4)
was plotted against unlabelled [Tβ4]. Error bars represent s.d. (n=3).
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Discussion
In the present study, a new perfusion chamber to study platelet adhesion in vitro was
introduced. To validate the chamber, platelet deposition onto collagen and fibrinogen was
determined using Ca2+ and ADP as activating agents.
The average rate constant of platelet accumulation obtained under the various
conditions (immobilized collagen and fibrinogen with Ca2+ and ADP as agonists) was
0.026±0.0015 s−1. This rate constant corresponds to a half-life of 27 s. This indicates that
the deposition process in the flow system is complete by ~130 s (i.e. 5× half-life). This
value corresponds well to 2 min to 6 min bleed times (i.e. the time it takes for a small skin
wound to stop bleeding) in normal humans (Schafer et al 2003). There were also no
statistically significant differences in the total number of platelets deposited to the flow
cell surfaces covered with fibrinogen or collagen which is indicative of the reproducibility
of the immobilization methodology employed here.
Platelets have high concentrations of Tβ4 and during blood clotting, Tβ4
concentration in the serum increases substantially. During blood coagulation, or by ADP
induced aggregation of platelets, Tβ4 is liberated from platelets and partially cross-linked
to fibrin by a transglutaminase, factor XIIIa. The covalent cross-linking of Tβ4 to the
fibrin clot might represent a mechanism to guarantee a high local concentration of the
peptide at the site of injury, probably supporting subsequent wound healing.
When Tβ4 was added to the blood, there was an increase in platelet deposition as
compared to the controls. However, at high concentrations of Tβ4, the platelet deposition
diminished. In terms of the half-life of deposition, this corresponds to a decrease from 27
s to 17 s (i.e. deposition is complete in ~85 s in the presence of Tβ4 as opposed to ~130 s
in its absence). Interestingly, as the concentration of Tβ4 reaches ~2 μM the deposition
rates and density return to near normal levels.
One possible explanation for Tβ4-mediated transient in platelet deposition could
be that Tβ4 has multiple effects on platelet thrombus formation. At low concentrations
Tβ4 could promote platelet activation by interacting with platelet receptors (ADP,
fibrinogen, etc.) converting them to high affinity states. Tβ4 could also bind to fibrinogen
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in such a manner to prevent its interaction with platelet receptors, thus as Tβ4
concentrations rise, platelet deposition would be attenuated.
The binding of Tβ4 to fibrinogen and fibrin in the presence and absence of
transglutaminase was tested previously (Makogoneko et al 2004). In these studies,
fibrinogen was attached onto plastic, blocked and the amount of Tβ4-bound was
estimated by anti-Tβ4-antibodies conjugated to horse radish peroxidase. The
concentration range of Tβ4 employed was 5 μM to 30 μM. Although these authors did
observe the largest amounts of Tβ4 incorporation to fibrin in the presence of
transglutaminase, they did report a small amount of Tβ4-binding to fibrinogen
(Makogoneko et al 2004).
Our present result suggests that there is a high affinity Tβ4-binding domain on
fibrinogen that was previously undetected possibly owing to differences in the Tβ4-dose
or the binding assays employed. The fibrinogen binding ability of Tβ4 could explain the
biphasic response of Tβ4 on platelet deposition under conditions of flow as observed
here.
Furthermore, the results obtained in this study suggest a key modulatory role for
Tβ4 in thrombus formation. At low doses Tβ4 promotes platelet deposition and
aggregation by as yet unknown mechanism(s). But as platelets are activated and more
Tβ4 is released from platelets, its serum levels rise and prevent excessive thrombus
formation by binding to fibrinogen and preventing its interaction with platelets. It is also
very tantalizing to postulate that platelets hyperactivity in pathologies like type 2 diabetes
can result from deficiencies in intraplatelet Tβ4. The consequences of this would be that
more actin would be polymerized in the resting platelet and less Tβ4 would be released
into the blood during platelet activation to modulate the inhibitory phase by binding to
fibrinogen thus resulting in platelet hyperactivity.
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Conclusions
These results suggest that Tβ4 could potentially increase the affinity of platelet receptors
for their ligands thus promoting platelet deposition. Tβ4 could also bind to fibrinogen and
as its concentration increased would prevent platelet–fibrinogen interactions resulting in
the attenuation of platelet deposition. This work suggests that Tβ4 might have a dual role
in platelet function.
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CHAPTER 5

Thymosin beta 4 alleviates endoplasmic reticulum stress in
retinal pigment epithelial cells
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Introduction
Endoplasmic reticulum (ER) stress is caused by the accumulation of unfolded proteins in
the endoplasmic reticulum lumen. It has been implicated in the pathogenesis of many
neurodegenerative diseases including Alzheimer’s, Parkinson’s and Huntington’s disease
(Li et al 2008). All of these diseases are similar to age related macular degeneration
(AMD) in various pathological features. It has been recently proposed that ER stress
might have an important role in the pathogenesis of AMD (Salminen et al 2010). It has
also been shown to play a critical role in the early stages of diabetic retinopathy
progression (Li et al 2009). ER stress has been triggered by chronic ocular hypertension
in glaucoma mouse models, which leads to retinal ganglion cell death (Doh et al 2010).
The retinal pigment epithelium (RPE) is a monolayer of pigmented simple
cuboidal cells, which performs many functions essential for vision. The basolateral
membrane of the RPE faces the Bruch’s membrane and the apical membrane faces the
photoreceptor outer segments. RPE has many critical functions including transport of
nutrients (Vitamin A and C) from blood to retina, phagocytosis of the shedded
photoreceptor membranes, setting up the ion gradients within the interphotoreceptor
matrix and building up the blood-retina barrier. RPE dysfunction is central to the
development of AMD.
Age related macular degeneration (AMD) is the leading cause of loss of central
vision in elderly individuals. AMD is characterized by morphological and functional
abnormalities in RPE cells (Binder et al 2007). The pathogenesis of AMD involves the
buildup of drusen between Bruch’s membrane and RPE and accumulation of lipofuscin, a
pigmented aggregate of proteins and lipids, in RPE. Subretinal neovascularization, which
occurs due to VEGF overexpression in the RPE, is a major development of AMD.
Recently, it has been shown that ER stress causes increased expression of VEGF (Roybal
et al 2005).
Oxidative stress is a very important factor in the progression and onset of AMD
and can initiate ER stress in RPE (Beatty et al 2000, He et al 2008). It has been recently
proposed that ER stress might play an important role in the pathogenesis of AMD (Libby
et al 2010).
Thymosin  4 (Tβ4) is a water-soluble, 43 amino acid polypeptide with a
117

molecular weight of 4.9kDa (Low et al 1981; Yu et al 1994). It is a major G actin
sequestering protein in mammalian cells. Tβ4 has diverse biological roles including
angiogenesis, cell migration, tissue protection, and regeneration in skin, eyes and heart. It
has been previously reported that Tβ4 decreases inflammation and promotes wound
healing in corneal epithelial cells (Sosne et al 2002). Internalization of Tβ4 has been
reported in human corneal epithelial cells, HUVEC, bovine corneal endothelial cells and
human bone marrow-derived mesenchymal stem cells (Grant et al 1999; Ho et al 2007).
Herein we hypothesize that ER stress might play an important role in the RPE
damage during AMD and that Tβ4 can mitigate those effects. In the present study, we
report that Tβ4 can alleviate ER stress in retinal pigment epithelial cells.
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Experimental methods
Cell Culture and treatment
Human retinal pigment epithelium cell line ARPE 19 was obtained from ATCC. Cells
were grown in 1:1 mixture of Dulbecco’s Modified Eagle’s Medium with Ham’s F-12
nutrient medium (DMEM F-12; ATCC, USA), 10% fetal bovine serum (FBS, Sigma,
Canada) and penicillin – streptomycin (Gibco, Canada). The cells were either plated on
coverslips in 35 mm plates or in 100 mm plates and were incubated at 37°C in 5% CO 2 to
reach ~70% confluence before the experiments. The ARPE 19 cells were incubated with
either 0.2M or 2M of T4 for 1 hour before inducing ER stress by adding 500 M
palmitate (Sigma, Canada) in 0.5% BSA (Sigma, Canada). The cells were then incubated
at 37°C in 5% CO2 for 24 hours.
Cell viability
Cell viability was determined by annexin V and trypan blue staining. For Trypan Blue
exclusion, cells were seeded in 6 well plates (100,000 cells/well) and grown overnight.
The cells were treated with Tβ4 and palmitate as described before. After 24 hour
incubation, the cells were trypsinized and 100μl of the cell suspension was incubated with
an equal volume of 0.4% Trypan blue solution (Gibco, Canada) for 2 min. Cells were
counted using a hemocytometer on a light microscope, where live cells excluded Trypan
Blue staining. For annexin V staining, an annexin V staining kit (BD Biosciences) was
used. ARPE 19 cells were grown on coverslips in 35mm cell culture plates. The adherent
cells were incubated with annexin V and propidium iodide (PI) for 15 min. The cells were
fixed with 3% paraformaldehyde, washed with PBS and viewed under fluorescence
microscope with a dual filter set for FITC (Annexin V) and rhodamine (PI).

Intracellular ROS production
The dye H2DCFDA dye is used to detect intracellular ROS. ARPE 19 cells grown on
coverslips were incubated with H2DCFDA for 30 min at 37°C. The cells were washed
with PBS 3X and viewed under fluorescence microscope with excitation at 488nm and
emission at 530nm.
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Cholesterol detection
Cholesterol estimation was done by using filipin (Sigma, Canada). For filipin staining, the
cells were fixed in 3% paraformaldehyde for 30 min and were then washed 3 times with
PBS. The fixed cells were incubated with 0.05mg/mL filipin (Sigma, Canada) for 1 hr in
dark. After incubation, the cells were washed 3X PBS and slides were mounted on slides
with fluoromount G (Southern Biotech). The slides were viewed under a fluorescent
microscope using a UV filter with excitation at 340-380 nm and emission at 385-470 nm.
To detect cholesterol, ARPE 19 cells were also stained with 750 nM PFO-D4-GFP for 30
min at 37 °C and 5% CO2. The cells were washed three times with HEPES buffer and
images were taken on an Axiovert fluorescence microscope with 535 nm/550 nm
excitation/emission.
Nitric oxide measurement
ARPE-19 cells were seeded at a density of 2X105 cells in a 10cm plate and were used
after they reached ~90% confluence. The cells were pretreated with Tβ4 for one hour and
then incubated in the presence of palmitate for 24 h. After the termination of the treatment
times, media was aspirated and fresh media was added. The cells were incubated again
and after 1 hr, 200 uL of media was withdrawn with a Hamilton gastight syringe and
directly injected into the purge vessel of a Sievers Nitric Oxide Analyzer (Model 280i)
which contained acetic acid and sodium iodide. A portion of NO produced by ARPE 19,
is oxidized by oxygen to form nitrite in the media. The acidified iodide in the purging
chamber of the NOA then reduces nitrite to NO. To further determine changes in NO
production, ARPE 19 cells were incubated with cell culture medium containing 5 M ,
4,5-diaminofluorescein diacetate (DAF-DA , Invitrogen) at 37°C in a 95% air/5% CO2
incubator for 30 min. Cells were then washed 3X with phosphate buffered saline (PBS)
and mounted on the stage of an Axiovert 200 inverted fluorescence microscope. DAF-DA
fluorescence was monitored using excitation and emission wavelengths of 485 and 538
nm, respectively.
Immunofluorescence
ARPE-19 cells were grown on coverslips in 35mm cell culture dishes. For the study of
nuclear translocation of NF-κB, cells were incubated with 500M palmitate for 24 hours,
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with or without Tβ4 pretreatment. After incubation, the cells were washed with PBS and
fixed in ice cold ethanol for 10 min. Rabbit polyclonal antibody against the p65 subunit of
NFκB (1:200 dilution; Abcam) was used as the primary antibody. Alexa Fluor 488 labeled goat anti-rabbit IgG was used as a secondary antibody (1:500 dilution; Santa Cruz
Biotechnology). Preparations were mounted in Fluoromount G and examined by
fluorescence microscopy.
Nuclear and cytoplasmic fractions
After treatments, ARPE-19 cells were trypsinized, resuspended and homogenized in
buffer A (10 mM HEPES pH 7.8, 10 mM KCl, 1.5 mM MgCl2, 0.5% Nonidet P-40, 1
mM dithiothreitol (DTT) and protease inhibitor cocktail (Sigma)). Nuclei and cytosolic
fractions were separated by centrifugation at 1000g for 20 minutes. The cytosolic
fractions (supernatant) were stored at −80°C until further analysis. The nuclear fractions
(pellets) were resuspended in buffer B (5mM HEPES pH 7.8, 1.5mM MgCl2, 0.2mM
EDTA, 1mM DTT, 26% glycerol, 300mM NaCl pH 7.8 and protease inhibitor cocktail).
Nuclei were extracted for 30 min at 4°C. Soluble nuclear fractions were obtained by
centrifuging at 12,000g for 10 min. Supernatants (nuclear extracts) were stored at −80°C
until further NFB analysis. Protein concentration was determined by the BCA method.
Western blots
Proteins were extracted from ARPE 19 cells with lysis buffer (10g/L sodium
deoxycholate, 1% Triton X, 0.01% SDS, 150mM NaCl, 50mM Tris pH 7.5, 0.05 mM
EDTA, 50mM NaF, 10mM sodium pyrophosphate, 0.5mM sodium peroxyvanadate and
protease inhibitor cocktail). Protein concentration was determined by the BCA method.
10 μg of protein samples were resolved in 10% sodium dodecyl sulfate–polyacrylamide
gel and transferred onto polyvinylidene fluoride (PVDF) membranes. Membranes were
probed with primary antibodies against anti-rabbit eNOS (1:1000; Abcam), anti-rabbit
phospho-eNOS (1:1000; Cell Signalling), anti-rabbit p65 subunit of NFκB (1:1000;
Abcam), anti-rabbit Grp78 (1:1000; Abcam), anti-mouse PDI (1:1000, Abcam), antirabbit Topo II (1:500; Santa Cruz) and anti-mouse actin (1:5000; Abcam). Membranes
were then incubated with HRP-conjugated anti-rabbit and anti-mouse secondary
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antibodies (1:2000; Abcam) for 1 h and visualized using enhanced chemiluminescence
reagent (Pierce, USA).
Statistical analysis and images
Data is expressed as an average of all trials and statistical analysis was performed by
Student's t-test. The error bars represent standard deviation. The images were captured
with a Zeiss Axiovert fluorescence microscope and analyzed using Northern Eclipse.
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RESULTS
Cell viability
The cells under ER stress for prolonged periods eventually undergo apoptosis. Apoptosis
is detected by the flipping of phosphatidylserine from the inner leaflet of the plasma
membrane to the outer leaflet. We determined the viability of the cells using FITCAnnexin V, which binds to phosphatidylserine and detects apoptosis. PI was used to stain
the nucleus of viable cells. As shown in Fig. 1A, no apoptotic signal is observed in
controls and cells pretreated with 2 µM Tβ4. Very little annexin V binding is seen in cells
which were under ER stress (no Tβ4 pretreatment) and those pretreated with 0.2µM Tβ4.
The trypan blue exclusion assay showed that ~92% cells were viable in the controls;
however the cell viability decreased to ~78% in palmitate treated cells. The ARPE 19
cells which were pretreated with 0.2 µM and 2 µM Tβ4 had 80% and 82% viable cells
respectively (Fig. 1B). These results illustrated that after induction of ER stress for 24
hours, the cells are still viable and healthy and can be used for the subsequent studies.
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Figure 1 –
Detection of apoptosis and cell viability in ARPE 19 cells treated with
palmitate with or without Tβ4.
ARPE 19 cells were treated with 500 µM palmitate in the presence and absence of Tβ4
concentrations as indicated. (A) After 24 hours, cells were stained with PI (red) and
apoptotic cells were detected by Annexin V staining (green). Images were taken of a
minimum of five different fields in a slide using a 40X oil immersion objective. (B)
ARPE 19 cells were treated with palmitate and Tβ4 as described before. Live and dead
cells were determined using the trypan blue exclusion assay. The results are presented as
percentage of cell viability. Data is shown as mean ± S.D (n=4).
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Induction of ER stress markers by palmitate
Grp78 and PDI are very important markers for ER stress induction. These molecular
chaperones are upregulated in response to ER stress. As shown in Figure 2, palmitate
treatment upregulated expression of Grp78 and PDI proteins which indicates induction of
ER stress. The Grp78 protein levels are brought down to normal (almost similar to
controls) when ARPE 19 cells were pretreated with 0.2 µM Tβ4 before inducing ER
stress.
Control

ERS

ERS +
0.2µM TB4

PDI
Grp78
Actin

Figure 2 –
Expression of ER stress markers, Grp78 and PDI, in ARPE 19 cells
treated with palmitate in the presence or absence of T4.
ARPE 19 cells were treated with 500 µM palimate with or without Tβ4 for 24 hours.
Expression of Grp78 and PDI was determined from the cell lysates separated by SDSPAGE. The blots were probed with anti-rabbit Grp78 antibody and anti-mouse PDI
antibodies. Upper and middle panels show PDI and Grp78 expression in response to ER
stress and Tβ4 pretreatment and the lower panel shows actin, which was used as a loading
control. The graphs depict the blot densities determined by using Image J (n=3); * P <
0.05.
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Tβ4 attenuates ER stress induced cholesterol production
ER stress is known to increase cholesterol levels in cells. Increased cholesterol
accumulation in RPE has also been associated with the pathogenesis of AMD (Curcio et
al 2005). The cholesterol determinations in ARPE-19 indicated that there was a ~4.5 fold
increase in cholesterol in cells under ER stress as compared to controls, however, treating
the cells with 0.2µM Tβ4 before ER stress induction significantly reduced cholesterol
levels by ~20%. Pretreatment with 2µM Tβ4 further decreases the cholesterol levels by
~27% (Figure 3).
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Figure 3 – Effect of Tβ4 pretreatment on cholesterol in retinal pigment epithelial
cells under ER stress.
ARPE 19 cells were treated with palmitate for 24 hours, in the presence or absence of
Tβ4. (A) The cells fixed with 3% paraformaldehye were stained with filipin (blue) and PI
(red) and examined by fluorescence microscope. Filipin stains intracellular cholesterol
and PI stains the nucleus. The pictures were captured using 40X oil immersion objective
The graph depicts average fluorescence of filipin from four separate experiments (± SD);
*** P < 0.001. (B) Cholesterol was also estimated by staining with PFO-D4-GFP. After
treatment, the cells were incubated with PFO-D4-GFP at room temperature. After 30 min
incubation, the cells were fixed with 3% paraformaldehyde and visualized under
fluorescence microscope using 40 X oil immersion objective. The graph represents
average fluorescence of PFO-D4-GFP ± SD (n=4); *** P < 0.001.
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Tβ4 pretreatment decreases ER stress induced ROS production
Oxidative stress is associated with the onset of ER stress and is one of the most important
factors associated with the progression of AMD. H2DCFA, a cell permeable dye which
incorporates into the hydrophobic regions of the cell, was used for this purpose. The
cellular esterases cleave the acetate moiety leaving impermeant, non-fluorescent, 2′,7′dichlorodihydrofluorescein (H2DCF), which is oxidized by reactive oxygen species to
fluorescent dichlorofluorescein (DCF). To determine whether Tβ4 has the ability to
reduce reactive oxygen species (ROS) formation after induction of ER stress, the levels of
ROS were determined. It can be clearly seen in Figure 4 that ER stress increased ROS
production by ~ 4 fold. Pretreatment with 0.2µM Tβ4 decreased ROS production by ~
42%. Higher concentration of Tβ4 (2µM) was able to reduce ROS formation by ~ 57%.

129

H2DCFDA fluorescence

90
80

***

70
60
50

***

40

***

30
20
10
0
Control

ERS

ERS+0.2uM TB4 ERS+2uM TB4

Figure 4 – Effect of Tβ4 pretreatment on intracellular ROS production in ER stress
induced retinal pigment epithelial cells.
ARPE 19 cells were incubated with 500 µM ER stressor palmitate, with or without Tβ4
(0.2μM or 2 µM) for 24 hours. The cells were analyzed for intracellular ROS using
H2DCFDA. The fluorescence (green) is generated by the oxidized product of H2DCFDA,
which indicates ROS formation. The graph shows an average of H2DCFDA fluorescence
and the results are an average of five different set of experiments (n=4); *** P < 0.001.
Pictures were taken using 63X objective.
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Tβ4 promotes nitric oxide production and eNOS phosphorylation
The palmitate treated cells were compared with the controls and Tβ4 pre treated cells with
respect to nitric oxide production. The nitric oxide was determined in the media, which is
an indirect method to analyze changes in nitric oxide production by cells. ER stressor
palmitate decreased nitric oxide production by ~ 55%, but NO production was
upregulated by ~ 88% in the cells which were treated with Tβ4 before inducing ER stress
as compared to cells under ER stress (Figure 5A). To further verify the role of Tβ4 in
nitric oxide production, eNOS expression and phosphorylation was determined. The
activity of eNOS is increased by its phosphorylation at Ser 1177. As illustrated in Figure
5C, there is no significant difference in the expression of eNOS in palmitate treated cells
as compared to the control and Tβ4 pretreated cells. eNOS phosphorylation decreased
after induction of ER stress by palmitate, whereas pretreatment with 0.2µM Tβ4
upregulated the phosphorylation of eNOS.

131

A

B

132

C

eNOS blot density

6000
5000

4000
3000
2000
1000
0

Control

ERS

ERS+0.2uM
TB4

Figure 5 – Effect of Tβ4 on nitric oxide production, eNOS expression and
phosphorylation in retinal pigment epithelial cells under ER stress.
The ARPE 19 cells were treated with palmitate in the presence or absence of Tβ4 as
previously described. (A) After 24 hours, the cells were stained with 5µM DAF-DA for
30 min. The cells were washed with PBS and viewed under Zeiss Axiovert fluorescence
microscope using a 20X objective. The graph shows average intensity of DAF-DA
fluorescence from three independent experiments (± SD); * P < 0.05; ** P < 0.01. (B)
Total nitrite was measured for retinal pigment epithelial cells treated with palmitate for 24
hours with or without Tβ4. After treatment, the cell culture media was replaced with fresh
media and the cells were incubated again for 1 hour. The data shown is representative of
three different experiments (± SD); * P < 0.05; ** P < 0.01. (C) The expression of eNOS
and its phosphorylation at Ser 1177 was estimated from western blots using cell lysates of
control, cells under ER stress and cells treated with 0.2 µM Tβ4 before inducing ER
stress. The blots were probed with eNOS and Ser1177 phospho eNOS antibodies. Actin
was used as a loading control. The graph represents blot densities of eNOS and phospho
eNOS which were quantified using Image J software.
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Tβ4 reduces nuclear localization of NFκB
ER stress activates and induces the nuclear translocation of the transcription factor NFκB
(Pahl et al 1995; Kaneko et al 2003). As demostarted in Figure 6A, the
immunofluorescence staining of the p65 subunit of NFκB in control cells shows
cytoplasmic distribution. Incubation with ER stressor palmitate predominantly relocates
NFκB to the nucleus; however when the ER stressed cells were pretreated with 0.2 µM
and 2 µM Tβ4, this nuclear translocation was decreased, with large amounts of the p65
subunit being in the cytoplasm.

134

A

B

135

Figure 6 – NFκB localization in response to ER stress and T4 pretreatment.
(A) ARPE 19 cells were cultured on glass coverslips and treated with 500μM palmitate
with or without 0.2μM Tβ4 and 2μM Tβ4. The cells were fixed with ethanol and FITC
conjugated goat anti-rabbit secondary antibody was used to detect the p65 subunit of
NFκB. Nuclear localization of NFκB is shown by arrows. Images were taken at 40X oil
immersion objective. (B) Nuclear localization of NFκB was further detected by Western
blots of nuclear and cytoplasmic fractions. Relative levels of NFκB in nuclear fractions
were determined. There is a significant increase in nuclear NFκB protein in cells under
ER stress. Pretreatment with Tβ4 decreases NFκB localization to the nucleus in a
concentration dependent manner. Actin was used as a control for cytoplasmic fractions
and Topo II was used as a control for nuclear fractions.
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Discussion
RPE dysfunction is one of the key factors involved in the progression of AMD. Retina
and RPE are under constant oxidative stress due to high metabolic activity, oxygen
consumption and light absorption. The fluctuations in the redox environment and ROS
production leads to disturbances in the ER hence causing ER stress (Lai E et al 2007). ER
stress has been proposed to be an important parameter involved in the pathogenesis of
AMD. A recent study has shown increased expression of tight junctions in retinal pigment
epithelial cells in vitro. This has been shown to alter the function of RPE cells which
might be involved in AMD (Yoshikawa et al 2011). However, not many studies have
foccussed on the effects of ER stress on RPE cells so far.
Tβ4 is a major actin sequestering protein which plays an important role in various
other physiological processes. It decreases cytochrome c release from the mitochondria
and also increases the expression of anti-apoptotic gene, bcl-2 (Sosne et al 2005).
Previous studies have illustrated the role of Tβ4 in decreasing inflammation (Sosne et al
2002) and preventing apoptosis (Ho et al 2010).
In the present study, we illustrated the effects of ER stress on retinal pigment
epithelial cells and the ability of Tβ4 to alleviate ER stress in RPE. ER stress disrupts
protein folding in the endoplasmic reticulum leading to accumulation of unfolded
proteins. An unfolded protein response (UPR) is initiated in order to maintain cell
homeostasis. UPR upregulates expression of chaperone proteins in order to augment the
protein folding capacity of the ER. When UPR is not able to alleviate ER stress, it
initiates an apoptotic signaling pathway, which involves JNK and caspases (Harding et al
2002; Kaufman et al 2002).
In this study, we evaluated the expression of molecular chaperones in retinal
pigment epithelial cells, in response to ER stress. Grp78 and PDI protein expression were
upregulated in the cells treated with palmitate, however, Tβ4 decreases the expression of
these chaperones (Fig. 2). The ability of Tβ4 to decrease Grp78 and PDI levels indicates
its potential role in protecting the cells against ER stress.
The role of oxidative stress in RPE dysfunction and AMD pathogenesis is very
well known. Previous reports have also linked oxidative stress with ER stress and RPE
dysfunction. The role of ER stress in RPE neovascularization in AMD has also been
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implicated (He et al 2008; Libby et al 2010). It has been demonstrated in a previous study
that there is accumulation of free and esterified cholesterol in the RPE of AMD patients
(Lakkaraju et al 2007; Curcio et al 2005). The results of our study showed that Tβ4
pretreatment decreases cholesterol production, which accumulates as a result of ER stress
(Fig. 3). Oxidative stress, which occurs due to excessive ROS formation, plays a very
important role in RPE dysfunction. It is illustrated by our results that Tβ4 is able to
reduce intracellular ROS in RPE and hence protect the cells from oxidative damage.
We next determined the effect of Tβ4 on NO formation. Previous reports have
suggested that there is less production of nitric oxide in the eyes of AMD patients (Bhutto
et al 2010). In the present study, we demonstrate that Tβ4 is capable of upregulating NO
production in cells under ER stress, however, when levels of eNOS were determined,
there was no significant difference in its expression in treated versus untreated cells.
There was, however a significant difference in the phosphorylation of eNOS at Ser1177,
in the cells which were pretreated with Tβ4 before induction of ER stress (Fig 5). It has
been previously reported that Tβ4 can increase eNOS phosphorylation at Ser1177 in
endothelial progenitor cells (Qiu et al 2009). These results strongly suggest that Tβ4 is
capable of increasing eNOS phosphorylation and hence NO production in ARPE 19 cells.
The induction of ER stress is also associated with the activation of the
transcription factor NFκB. It is found in the cytoplasm but upon activation it translocates
to the nucleus, where it further promotes the transcription of various pro-inflammatory
genes and hence inflammatory signaling pathways. We further show that Tβ4 can also
decrease nuclear localization of NFκB (Fig. 6). Our observations agree with a previous
study done in corneal epithelial cells which showed that Tβ4 can minimize nuclear
localization of NFκB after TNF-α stimulation (Sosne et al 2007).

Conclusions
In summary, the present preliminary study demonstrates the protective effects of Tβ4 in
retinal pigment epithelial cells under ER stress. More work is required to be done in this
field to determine the protective effects of Tβ4 in AMD and other retinal diseases.
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CHAPTER 6

General Discussion
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Laminar shear stress is very critical for maintaining proper vascular hemostasis
functioning and hemostasis. From a clinical standpoint, shear stress is one of the most
potent endothelial stimulators and it plays an important role in numerous processes
including vasoregulation, chronic adaptive vessel remodeling (Helmke et al 2002),
maintaining vascular homeostasis by inhibiting endothelial responses to cytokine
stimulation (Chiu et al 2002) and in the development of atherosclerosis. Previous studies
have shown that areas with low and oscillating shear stress are more prone to
atherosclerosis (Moore et al 1994; Pedersen et al 1999).
Platelet adhesion and thrombus development also depends on the local
hemodynamic environment to a large extent (Mustard et al 1966). Shear stress plays an
important role in transporting platelets and mediating their adhesion at the site of injury.
To understand the mechanisms responsible for platelet function under low and high shear
rates, many studies have focused on the platelet adhesion to various matrices (fibrinogen,
collagen) under flow conditions. In all of these studies, coating of glass slides with
fibrinogen, collagen or vWF has been reported and these flow devices were then used to
study platelet aggregation mechanisms (Neeves et al 2008; Fuchs et al 2010, Giesen et al
1999). This might result in heterogeneous coating and not all the surface might be coated.
To understand the role of physiological and pathological shear stress in various
vascular diseases, many flow devices have been engineered (Andrews et al 2010; Man et
al 2009; Shepherd et al 2009). These flow devices require a large population of
endothelial cells which needs more chemicals and reagents. Recently, many studies have
developed microfluidic flow chambers which are very costly. Out of the various flow
devices available to study effects of shear stress, parallel plate flow chambers are the
most common. Parallel plate flow chambers are used to mimic flow conditions occurring
in vivo and study the dynamic response of vascular endothelial cells and platelets to
controlled levels of fluid shear stress.
This thesis describes the development and validation of flow devices to study
effects of shear stress on endothelial cells and platelet aggregation. The parallel plate flow
chamber described in here can be used to study shear mediated effects on endothelial cells
and platelets. These flow devices are very versatile and economical to make and allow
real time study of the platelets and endothelial cells exposed to shear stress. In the present
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study, I report the construction of another flow device for studying platelet function, in
whole blood, in real time. In these flow chambers, the inert polydimethylsiloxane
(PDMS) surface was plasma-activated and a homobifunctional cross-linker was used to
immobilize platelet-binding proteins onto its surface. The current study introduces a new
facile and robust method for the construction flow chambers which enable the kinetic
monitoring of platelet adhesion in whole blood.
Type 2 diabetic patients are at a greater risk of developing vascular diseases like
atherosclerosis. Increased levels of fibrinogen have been reported in diabetes, which
might contribute to abnormal clot formation in diabetic patients (Banga et al, 1986).
Plasmin activator inhibitor 1 (PAI 1) inhibits the formation of plasmin from plasminogen.
Increased levels of this inhibitor have also been found in the diabetic blood (Juhan-Vague
et al, 1989). Previous studies have also shown increased levels of vWF activity in
diabetes (Van Zile J et al 1981). All of these factors contribute to the formation of a
prothrombotic state in the diabetic patients.
The flow chamber developed in this thesis was used to study platelet aggregation
in diabetic subjects in vitro. The flow chamber was able to discern differences between
platelets from normal and diabetic subjects. These flow devices provide real time data on
the kinetics of platelet binding and can detect subtle pathological changes in platelet
function introduced as a result of pathologies such as type 2 diabetes.
Tβ4 is a 43 amino acid peptide found in various tissues and cells including
platelets. It has been implicated in the sequestering of G actin in mammalian cells. Tβ4
plays an important role in preventing apoptosis, corneal wound healing, cell survival and
angiogenesis (Sosne et al 2004; Hinkel et al 2008; Smart et al 2007).
The aim of this work was to evaluate the role of Tβ4 in various physiological
processes. It has been shown previously that Tβ4 is secreted by platelets and is
crosslinked by factor XIIIa (a transglutaminase) to fibrin in a time- and Ca2+-dependent
manner (Huff et al 2002; Makogoneko et al 2004). This increases the local concentration
of Tβ4 near sites of clots and tissue damage, where it is postulated to contribute to wound
healing, angiogenesis and inflammatory responses. Yet the role of Tβ4 on platelet
thrombus formation has yet to be fully investigated.
The current study represents a preliminary effort towards this goal. Here, we have
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tested the effects of Tβ4 extraneously added to whole blood, on deposition of ADP
activated platelets onto fibrinogen under conditions of continuous flow and shear. There
was an increase in platelet deposition when Tβ4 was added to the blood, as compared to
the controls. However, at high concentrations of Tβ4, a decrease in the platelet deposition
was observed. The results of the present study suggest that there could be a high affinity
Tβ4-binding domain on fibrinogen. The fibrinogen binding ability of Tβ4 could explain
the biphasic response of Tβ4 on platelet deposition under conditions of flow as observed
here. Furthermore, the results obtained in this study suggest a key modulatory role for
Tβ4 in thrombus formation. At low doses Tβ4 promotes platelet deposition and
aggregation by as yet unknown mechanism(s). But as platelets are activated and more
Tβ4 is released from platelets, its serum levels rises and prevent excessive thrombus
formation by binding to fibrinogen and preventing its interaction with platelets.
Tβ4 has also been shown to decrease inflammation and promote corneal wound
healing, and various studies have given evidence supporting the role of Tβ4 in cornea
protection (Ho et al 2008; Sosne et al 2007; Dunn et al 2010). This thesis also
investigates the effects of Tβ4 on endoplasmic reticulum stress in retinal pigment
epithelial cells. In this study, we illustrated that Tβ4 is able to reduce ROS production,
which is an important factor associated with the progression of various ophthalmologic
diseases including AMD and DR (He et al 2008; Libby et al 2010). Tβ4 also promotes
NO production and decreases NF-κB nuclear localization in RPE. Our observations agree
with a previous study done in corneal epithelial cells which showed that Tβ4 can
minimize nuclear localization of NFκB after TNF-α stimulation (Sosne et al 2007). The
results reported in this thesis demonstrated that Tβ4 can mitigate the effects of ER stress
in RPE cells.
Overall, the work done in this thesis has done significant contributions in
understanding the role of Tβ4 in thrombosis. However, more work is needed in this field
to fully understand the role of Tβ4 in thrombosis and evaluate the mechanisms and
signalling pathways involved in this process. Very few studies have reported any role of
ER stress in retinal diseases and this is one of those few studies. This thesis also presents
preliminary data which demonstrates the protective effects of Tβ4 in retinal pigment
epithelial cells under ER stress. More extensive study needs to be done in future in this
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field to get better understanding of the mechanisms involved. In conclusion, the work
presented in this thesis has made major contributions in development of flow devices to
study thrombosis and endothelial cell function under flow. This work is also a very
important step in studying the role of Tβ4 in various physiological processes.
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APPENDIX
The results presented in this section of the thesis relate to the studies in Chapter 2 of this
thesis.

Background
Earlier it was assumed that in parallel plate flow chambers, all cells are subjected to the
same average shear stress. However recently it has been hypothesized that cells are
subjected to variable shear stress depending on the area in the flow chamber (McCann et
al 2005). The objective of this study is to develop a flow device to study effects of shear
stress on endothelial cells and also to develop computational fluid dynamic (CFD)
template with different shear rates. The templates are designed to match the geometry of a
custom built in vitro flow cell device and define several regions of shear stress to which
the cells are exposed during in vitro experiment. Since it has previously been reported
that shear stress is correlated to NO production in endothelial cells, NO was measured in
order to validate the proposed flow device and the shear stress template.

Experimental Methods
Cell Culture
Human dermal microvascular endothelial cells (HDMECs) were purchased from
ScienCell. The cells were cultured in endothelial cell media (ECM, ScienCell) containing
10% fetal bovine serum (FBS, ScienCell), pencillin-streptomycin (ScienCell) and
endothelial cell growth supplement (ECGS, ScienCell) at 37ºC in a 5% CO2 incubator.
The flow chambers were coated 0.1% fibronectin overnight and endothelial cells were
grown until 95% confluent.
In vitro set-up
The flow cell circuit used for this investigation consists of a custom designed flow cell,
sterile tubing, a medium reservoir, and a peristaltic pump. The entire set-up was kept at
37ºC in a 5% CO2 incubator. The cells were exposed to shear stress for 12 hours.
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Fluorescence Indicator (DAF-2)
To determine changes in NO production, endothelial cell monolayers were incubated with
cell culture medium containing 5 M, 4,5-diaminofluorescein diacetate (DAF-DA ,
Invitrogen) at 37°C in a 95% air/5% CO2 incubator for 30 min. In the presence of oxygen,
DAF-2 reacts with NO to yield the highly fluorescent triazolofluorescein (DAF-2T). The
fluorescence was monitored using excitation and emission wavelengths of 485 and 538
nm, respectively.

Results
Geometry of the flow cell
The flow cell has the dimensions shown in Figure 2. The total area on the flow cell
surface available for cell growth and attachment was 6.85 x 10-5m2. The walls of the flow
cell are made of PDMS (Dow Corning) and the cells are grown on a glass coverslip.

Figure 1 – Geometry of the custom flow cell.
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Velocity gradient template
To simulate the flow in the chamber and estimate the shear stress for the testing program,
a computational model of the flow channel was developed.

1mL/min

Figure 2 – Velocity gradient template.
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Endothelial morphology in response to shear stress
The human dermal microvascular endothelial cells were exposed to laminar shear stress
for 12 hours hours and morphological changes were observed using light microscope. The
cells become elongated and aligned in the direction of flow; however no such change was
observed in endothelial cells maintained under static conditions.

Figure 3 – Morphology of endothelial cells grown under static and laminar shear
stress conditions.

Effect of shear stress on NOx production
In order to validate the flow chamber can be employed for studies in the areas of
biomedical research; the effect of fluid shear stress on nitric oxide production in
endothelial cells was examined. NOx formation was upregulated when cells were grown
under shear as compared to static conditions. The increase in NOx production was more
in endothelial cells which were exposed to high shear stress for 12 hours, compared with
those under low shear (Fig. 3).
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Figure 4 – NOx upregulation in response to shear stress.
HDMECs were exposed to shear stress for 12 hours and then stained with 5 μM DAFDA. The regions exposed to high shear stress had increased NO production. The graph
depicts the average fluorescence intensity of DAF-DA (± SD).
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Discussion
Shear stress plays a critical role in maintaining vascular hemostasis and also in the
pathogenesis of various diseases, particularly atherosclerosis. Numerous studies have
focussed on investigating the effects of shear stress on endothelial cells. Parallel plate
flow chambers are commonly used for this purpose.
In this study, we describe the development and validation of a flow chamber for
shear stress studies. It has previously been shown that the endothelial cells align in the
direction of the flow and that the alignment would be more pronounced at areas of higher
shear. Our results also agree with these studies and show similar results.
There was an increase in NO production in regions of high shear. These findings
are in agreement with the previous studies which reported NO upregulation in response to
shear stress. These results suggest that this chamber can be used to study shear stress
effects on endothelial cells. This chamber is very simple to make, convenient to use and
inexpensive. It can be re used and requires very less number of cells. The shear stress
template described in here, can be used to define different regions of known shear stress.
This allows simultaneous exposure to different shear stress levels within one flow cell
under the exact same experimental conditions.
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